The Longevity Digest 06/16 - 06/22
I'm cutting through the noise in longevity and anti-aging podcasts so you don't have to.
Welcome to The Longevity Digest.
I’ve curated specific shows that consistently deliver evidence-based insights you can actually use. Think less fluff, more substance. The kind of information that changes how you practice or how you live.
Got a podcast that’s been delivering gold? Send it my way. I’m always hunting for voices that push the field forward.
This Newsletter Is Sponsored By Casa de Sante.
Dr Onyx MD PhD’s Insights on this week’s episodes
Your Biology Has a New Control Room — And It Isn’t Your Genes
The single most disruptive idea running through this week’s content is deceptively simple: the tools that control how you age are no longer exotic — they are measurable, modifiable, and accessible right now.paste.txt
On The Human Upgrade episode “Eat These Foods + Spices for 8 Weeks To Get 3 Years Younger” (Ep. 1461), Dr. Kara Fitzgerald delivered one of the most practically compelling findings of the cycle: an eight-week, food-first RCT reversed biological age by over three years on the Horvath epigenetic clock in healthy middle-aged men. The heavy lifters were methyl-donor foods — think leafy greens, eggs, beets, and liver — paired with seven to eleven cups daily of polyphenol-rich plants, herbs, and spices. The critical insight is that when exercise was controlled between groups, nutrients emerged as the primary driver. This is epigenetics without a lab coat: a plate is a prescription.paste.txt
The mechanism gets more interesting downstream. Urolithin A — featured in two Human Upgrade episodes (“The Biblical Anti-Aging Fruit That Scientists Are Obsessed With,” Ep. 1470) — activates mitophagy, your cell’s internal cleanup crew that selectively recycles dysfunctional mitochondria. Human data showed that 500 mg to 1 g daily for four weeks increased naïve CD8 T cells, NK cells, and mitochondrial gene expression in adults aged 50 to 70. Meanwhile, preclinical models showed roughly 45% lifespan extension in C. elegans. Here’s the clinician’s catch: only 30–40% of people can reliably convert pomegranate polyphenols into urolithin A, so supplement form is non-negotiable for consistent therapeutic dosing.paste.txt
Zoom out, and a coherent architecture emerges. On the Huberman Lab episode featuring Dr. Dacher Keltner (“Cultivating Awe & Emotional Connection in Daily Life”, April 2026), an eight-week awe-walk intervention in older adults measurably increased vagal tone (HRV), reduced physical pain, and lowered inflammatory markers. The same autonomic lever — the cholinergic anti-inflammatory pathway — appeared repeatedly on The Human Upgrade episode “Why Are Hackers Microdosing ‘Sex Drugs’ Now?” (Ep. 1425), where vagal nerve stimulation was shown to suppress the NLRP3 inflammasome, a master switch of systemic aging inflammation. EGCG (green tea extract) was flagged as a practical, low-cost adjunct. Your nervous system, it turns out, is your most under-prescribed internal pharmacy.paste.txt
This Newsletter Is Sponsored By Casa de Sante.
For anyone on GLP-1 medications like Ozempic or Wegovy, Low FODMAP nutrition is non-negotiable. These medications can slow digestion and trigger bloating or nausea, so choosing gut-friendly products helps you stay comfortable while protecting muscle and metabolism. Physician-formulated by Dr Onyx MD PhD Certified in Obesity Management, this Low FODMAP lineup supports nutrient absorption, muscle defense, and overall digestive balance:
Premium Protein Powder (Vegan Vanilla, Whey Vanilla, or Whey Chocolate) – helps preserve lean muscle during weight loss
FODMAP Digestive Enzymes – improves absorption and reduces GI side effects
Advanced Probiotic + Prebiotic Synbiotic Formula – supports a balanced gut microbiome
Essential Vitamin & Mineral Complex – replenishes nutrients often depleted during rapid weight loss
Gentle Colon Cleanse + Probiotic Support – aids regular elimination without irritation
All formulas are low FODMAP, non-GMO, and third-party tested—the ideal foundation for GLP-1 users focused on digestive comfort, metabolic health, and muscle preservation.
Because hormones and skin health are deeply connected, Dr Onyx MD PhD science-backed skincare supports barrier repair, hydration, and inflammation balance for healthy, resilient skin—especially during menopause or while using GLP-1 medications, when collagen loss and dryness can accelerate:
HydraLift Collagen Complex – firms and smooths for youthful elasticity
Antioxidant C+E Ferulic Radiance Serum – brightens and defends against oxidative stress
Needle-Free Wrinkle Smoother – softens fine lines without irritation
Ultra Retinol 10x + Bakuchiol Serum – boosts cell turnover with gentle plant retinol
Advanced Retinol Eye Repair – targets puffiness and under-eye wrinkles
Cellular Repair Growth Factor Peptides Serum – rejuvenates and supports skin repair
Advanced Neck Lift Firming Complex – improves tone and texture along the jawline and neck
Even Tone Brightening Cream – evens discoloration for radiant, balanced skin
Dr Onyx Adegbola MD PhD
Track Smarter. Eat Better. Thrive. Download the GLP1 Support App at https://casadesante.com/pages/app-glp-1-support-by-dr-onyx-md-phd
The New Threat Vectors Nobody Told You About
Longevity isn’t just about what you add to your biology — it’s about what you stop poisoning it with. This week surfaced a cluster of underrecognized exposures that are silently accelerating biological aging.paste.txt
Dr. William Li, appearing on The Human Upgrade episode “The Foods That Starve Cancer” (Ep. 1481), sounded what may be the most urgent environmental alarm of the digest cycle: microplastics embedded in carotid atherosclerotic plaques were associated with a roughly four-fold higher three-year risk of MI, stroke, and death. These particles enter primarily via inhalation (tire-wear particles are a leading source) and packaged ultra-processed foods. The clinical implication isn’t subtle — vascular inflammation monitoring via pulse wave velocity (PWV), not just LDL, should become standard risk assessment. HEPA filtration, cabin air filters, and elimination of plastic-packaged processed foods are no longer optional wellness upgrades; they are cardiovascular interventions.paste.txt
Then there’s what’s living inside your HVAC. The Human Upgrade episode “Your AC Is Making You Dumber” (Ep. 1444) with Dave Asprey and the SuperStratum team made the compelling case that mycotoxins from water-damaged buildings — particularly ochratoxin A and zearalenone — are mitochondrial poisons capable of driving neurocognitive deficits, sleep disruption, endocrine dysfunction, and weight dysregulation. Roughly 28% of people carry HLA-DR4 variants that prevent fat-soluble mycotoxin clearance, explaining why one family member crashes while others feel fine. The under-appreciated source? The car you drive to work. Basic protocol: measure indoor humidity (target 40–50%), HEPA vacuum dust, service HVAC ducts, and in symptomatic patients, run validated dust-based mycotoxin testing before escalating medications.paste.txt
In the same vein, The Human Upgrade episode “Superhuman Contact Lenses, Motivation Supplement Stack, Cat Scratches...” (Ep. 1448) noted that Bartonella — transmitted by cat scratches and bites — is a stealth intracellular infection consistently missed by standard serology. It presents as chronic brain fog, mood instability, and fatigue. PCR testing, not antibody panels, is required. For men, a Mendelian randomization of 270,000 participants linked higher circulating tyrosine to nearly one year shorter lifespan, potentially via myeloperoxidase-driven inflammation — a clear signal to stop reflexive tyrosine supplementation.paste.txt
The Strategic Plays Reshaping Longevity Practice in 2026
Beyond individual protocols, this week’s podcasts collectively sketch a strategic landscape that sophisticated clinicians need to map now.paste.txt
Metabolic health is the new oncology frontier. Acting CDC Director Jim O’Neill, featured on The Human Upgrade (“CDC Director Jim O’Neill on Fixing America’s Broken Food Policy,” Ep. 1449), confirmed a federal dietary pivot toward whole foods, adequate protein (1.2–1.6 g/kg/day), and a more individualized view of saturated fat — with RCTs on saturated fats underway and a $144M ARPA-H initiative to develop causal biomarkers of aging. Simultaneously, a Penn Medicine retrospective of ~111,000 women found GLP-1 receptor agonist use associated with 30–35% lower odds of breast cancer — an observational signal, but one consistent with the mechanistic logic of reducing insulin resistance, inflammation, and adiposity as oncological risk drivers. As Dr. Jason Fung argued on The Human Upgrade (“Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie,” Ep. 1453), sustainable fat loss is fundamentally a hunger biology problem — driven by hedonic and conditioned hunger amplified by ultra-processed foods — not a calorie-counting exercise. The clinical translation: diagnose and treat the hunger circuit, not the body weight.paste.txt
Social connection is a clinical biomarker, not a soft benefit. The Huberman Lab episode with Dr. Nick Epley (“How to Overcome Social Anxiety,” May 2026) synthesized evidence that brief, daily real-world interactions measurably improve mood and health — and that moving from zero to some social contact produces the largest gains. Dr. David Anderson’s Huberman Lab episode (“Essentials: The Biology of Aggression, Mating & Arousal,” April 2026) showed that chronic social isolation upregulates tachykinin 2 signaling — a druggable neurobiological state that amplifies aggression, fear, and anxiety reversible in preclinical models by NK3 receptor antagonism. The implication for practice: isolation is a modifiable risk factor with a measurable neurobiological substrate, not a lifestyle preference. Screen for it; prescribe against it.paste.txt
The circadian system is the operating system, not a feature. The Microbiome Medics episode “Eat to Sleep: The Power of Chrononutrition and Circadian Rhythms” (June 2026) and the Human Upgrade episode “Semen Switch, Chewing Gum, Creatine Cheat, Cancer Plants, and Bedtime Risk” (Ep. 1467) converged on a stark finding: objectively measured irregular bedtimes, combined with short sleep, were associated with double the risk of major cardiovascular events over a decade. Sleep regularity — not just duration — is an independent, modifiable cardiovascular risk factor. Pair this with the microbiome evidence that circadian disruption depletes Lactobacillus and Bifidobacterium, increases gut permeability, and drives downstream neuroinflammation, and the prescription writes itself: a fixed 90-minute bedtime window, morning light exposure, consistent meal timing, and high-fiber fermented foods are not wellness luxuries — they are the infrastructure on which every other longevity intervention runs.
This weeks episodes:
1. The Human Upgrade: Biohacking for Longevity & Performance
Why Are Hackers Microdosing “Sex Drugs” Now? : 1425
Published: 2026-03-03
URL: Listen Here
Summary
This episode advocates for precision medicine that integrates multi-omic data, autonomic modulation, and targeted therapeutics to optimize longevity. It highlights vagal nerve stimulation’s ability to downregulate the NLRP3 inflammasome, the need to individualize drugs and peptides, and the centrality of vascular tone/perfusion and mitochondrial function to healthy aging. Some claims are anecdotal and product-related; specific study details were not always provided in the discussion.
Key Takeaways
Precision medicine should move beyond one-size-fits-all epidemiology to N-of-1 care using multi-omics (genomics → transcriptomics → proteomics → metabolomics/exposome) to match the right intervention to the right person at the right time.
Vagal nerve stimulation engages the cholinergic anti-inflammatory pathway (α7nAChR/JAK–STAT/NF-κB) and can downregulate the NLRP3 inflammasome, a central driver of systemic inflammation and fibrosis; simple adjuncts like EGCG may also modulate NLRP3 activity.
Longevity pharmacology must be individualized: metformin is not universally beneficial (mitochondrial blunting/VO2 max concerns), rapamycin safety data are emerging (PEARL trial) but endpoints matter, and low-dose, pathway-targeted use of drugs and peptides (e.g., BPC-157, KPV, CJC-1295 with ipamorelin, PT-141) can have bioregulatory effects when used judiciously.
Vascular tone and perfusion are foundational to brain and sexual health; strategies include nitric oxide support, selective PDE5 inhibitor use (e.g., low-dose tadalafil in appropriate patients), and device-based approaches like acoustic shockwave therapy, which may promote neovascularization and lower MMP-9.
Actionable biomarkers beyond routine labs that inform aging biology include homocysteine, ApoB, Lp(a), TGF-β1, MMP-9, and C4a; pairing these with mitochondrial/energy-oriented interventions (IHHT, photobiomodulation, PEMF, HBOT) and exposome assessment can improve outcomes while AI can help sequence interventions efficiently.
Clinical Insight
Targeting autonomic balance and inflammatory set-points—specifically via vagal nerve stimulation to suppress NLRP3—combined with multi-omic profiling provides a practical, high-leverage way to personalize longevity care beyond traditional risk-factor management.
Actionable Takeaway
In patients with chronic inflammation or dysautonomia, add MMP-9 and homocysteine (along with ApoB, Lp(a), TGF-β1, and C4a when feasible) to baseline labs; if elevated, trial a noninvasive vagal nerve stimulation protocol to engage the cholinergic anti-inflammatory pathway and reassess biomarkers after 6–8 weeks.
2. The Human Upgrade: Biohacking for Longevity & Performance
Why Are Hackers Microdosing “Sex Drugs” Now? : 1425
Published: 2026-03-03
URL: Listen Here
Summary
This episode explores how precision medicine leverages multi-omics, exposome assessment, and autonomic modulation to individualize care, with practical discussion of peptides, low-dose pharmaceuticals (e.g., tadalafil), and advanced biomarkers beyond standard panels. The conversation emphasizes sequencing interventions for mitochondrial and vascular health, measuring transcriptomic responses to confirm epigenetic effects, and safeguarding data as personalized platforms mature.
Key Takeaways
Precision medicine requires an N-of-1, multi-omic approach (genomics, transcriptomics, proteomics, epigenetics, metabolomics, exposomics) to match the right intervention to the right person at the right time.
Autonomic modulation, particularly vagal nerve stimulation, can downregulate inflammatory pathways (e.g., NLRP3 inflammasome via the cholinergic anti-inflammatory pathway) and may improve longevity-relevant markers; EGCG was cited as a practical adjunct.
Microdosing or low-dose use of select pharmaceuticals (e.g., tadalafil for vascular tone) and emerging peptide therapeutics (e.g., BPC-157, KPV, CJC-1295 with ipamorelin/semorelin, PT-141) can be useful for targeted outcomes but should be sequenced thoughtfully; metformin and rapamycin are not universal longevity solutions.
Beyond routine labs, clinicians should consider biomarkers that reflect inflammation and vascular health such as homocysteine, MMP-9, TGF-β1, C4a, nitric oxide-related function, and even cell membrane lipidomics; low cerebral perfusion is common and clinically meaningful.
Biohacking technologies (e.g., intermittent hypoxic–hyperoxic training, photobiomodulation, PEMF, HBOT, acoustic shockwave) can be potent when applied in the right order and tracked with objective data; data privacy and ownership matter as multi-omic and exposome assessments scale.
Clinical Insight
Shifting from population averages to multi-omic, N-of-1 care—while actively modulating the autonomic nervous system—allows physicians to directly influence and verify changes in key inflammatory and vascular pathways (e.g., NLRP3, nitric oxide biology), improving precision and efficiency of interventions.
Actionable Takeaway
For patients with chronic inflammation, dysautonomia, or low perfusion, implement daily noninvasive vagal nerve stimulation (or paced-breathing/HRV training) for 10–20 minutes and track CRP/IL-6 and symptom changes; consider adding a well-tolerated green tea extract providing 200–400 mg EGCG/day as an NLRP3-modulating adjunct, checking for drug–supplement interactions.
3. The Human Upgrade: Biohacking for Longevity & Performance
Your AC Is Making You Dumber : 1444
Published: 2026-04-03
URL: Listen Here
Summary
This episode argues that air-conditioning and water‑damaged indoor environments expose occupants to mycotoxins that impair mitochondrial function, cognition, hormones, metabolism, and sleep, with variable susceptibility driven partly by HLA‑DR genetics. The hosts outline a cost‑conscious, stepwise approach to ‘detoxing’ homes and vehicles—fix moisture/HVAC, oxidize/degrade mycotoxins and VOCs, reseed with environmental probiotics, and protect high‑risk surfaces—alongside humidity and dust control. Limitations: many claims are experiential or product‑specific and not independently detailed in the episode; clinicians should interpret promotional elements cautiously and corroborate with evidence-based resources.
Key Takeaways
Toxic mold and their mycotoxins (e.g., ochratoxin A, zearalenone) are fat‑soluble mitochondrial poisons that can drive multisystem illness—neurocognitive deficits, sleep disturbance with vivid nightmares, mood/behavior changes, endocrine disruption (thyroid, estrogen dominance), weight gain, easy bruising, recurrent infections, and chemical sensitivity.
Susceptibility varies widely; genetics (e.g., HLA‑DR4 variants) and exposure history modulate risk, so one family member may be severely affected while others appear well. Brain SPECT data (Amen Clinics) suggest mold exposure can reduce prefrontal activity and cognition but may be reversible after remediation.
Built environments—especially HVAC systems, ductwork, dust, moisture-prone areas, and vehicles—are common and underrecognized exposure sources; ingestion via mold‑prone foods (coffee, grains, peanuts) also contributes.
Effective management pairs medical care with environmental strategies: identify and fix moisture sources, control indoor humidity (~40–50%), address HVAC and duct contamination, reduce dust, and consider staged decontamination (oxidizing fog/gas to degrade mycotoxins and VOCs, reseeding with environmental probiotics, and protective coatings on high‑risk surfaces).
Porous belongings can carry residual mycotoxins between homes; moving without decontaminating contents often perpetuates illness. Vehicles (cars/RVs) can be significant sources due to mold and VOCs; targeted ‘detox’ is different from standard detailing.
Clinical Insight
In patients with persistent, unexplained multisystem symptoms (fatigue/brain fog, sleep disruption, mood/behavior changes, weight dysregulation, chemical sensitivity), assessing and treating the home/vehicle environment—especially moisture control and HVAC/dust contamination—can be decisive for recovery from mycotoxin-related illness.
Actionable Takeaway
Screen for water‑damaged building exposure in symptomatic patients and recommend a basic home assessment: measure/maintain indoor humidity at 40–50%, use HEPA air filtration and HEPA vacuuming to reduce dust, inspect/clean HVAC and ducts, and initiate validated environmental testing (e.g., dust-based mycotoxin or ERMI/HERTSMI‑2) before escalating medications.
4. The Human Upgrade: Biohacking for Longevity & Performance
Your AC Is Making You Dumber : 1444
Published: 2026-04-03
URL: Listen Here
Summary
Dave Asprey and the SuperStratum team discuss how indoor mold and residual mycotoxins can impair mitochondrial function and contribute to wide-ranging symptoms, with variable patient susceptibility. They outline practical, staged approaches for homes and vehicles—addressing moisture control, HVAC/duct hygiene, dust removal, and targeted decontamination of mycotoxins/VOCs—to complement or follow traditional remediation.
Key Takeaways
The episode centers on indoor mold and mycotoxins as underrecognized drivers of diverse symptoms (fatigue, brain fog, sleep disturbance, mood changes, endocrine disruption, weight gain) via mitochondrial dysfunction and immune dysregulation.
Susceptibility varies widely; about 28% of people may carry HLA-DR4 variants associated with heightened inflammatory responses and reduced ability to clear fat-soluble mycotoxins, which helps explain why household members can be affected differently.
Common exposure sources include water-damaged buildings, high indoor humidity, HVAC/ductwork, dust accumulation, and vehicles; ochratoxin A (OTA) and zearalenone are highlighted as clinically relevant mycotoxins with thyroid and estrogenic effects, respectively.
Post-remediation illness can persist due to residual mycotoxins and VOCs on surfaces and in contents; the discussion emphasizes whole-home strategies: fix moisture sources, maintain 40–50% indoor RH, clean/coat HVAC and ducts, HEPA vacuum dust, and consider targeted decontamination approaches.
The guests discuss a staged approach they use (fogging/‘bombing’ to oxidize mycotoxins/VOCs, followed by environmental probiotics and durable anti-microbial coatings) as a lower-cost adjunct to traditional remediation, and note cars can require similar detox protocols.
Clinical Insight
In patients with otherwise unexplained neurocognitive, endocrine, sleep, or cardiometabolic complaints—especially with a history of dampness or water damage—environmental mycotoxin exposure is a plausible, often overlooked contributor; assessing susceptibility, the built environment (not just visible mold), and residual mycotoxins after remediation can materially influence outcomes.
Actionable Takeaway
Incorporate a brief environmental history and screening into visits for chronic, multisystem complaints: ask about water damage/musty odors, humidity levels, HVAC maintenance, visible condensation, dust burden, and car exposures; advise maintaining indoor RH ~40–50%, fixing moisture intrusions, HEPA vacuuming dust, servicing/cleaning HVAC and ducts, and consider referral to qualified mold assessment/remediation when indicated.
5. Huberman Lab
Cultivating Awe & Emotional Connection in Daily Life | Dr. Dacher Keltner
Published: 2026-04-06
URL: Listen Here
Summary
This episode details the science of awe—how shifting from narrow to vast perception, engaging with nature and music, and synchronizing in groups reliably evokes awe with tangible benefits across inflammation, vagal tone, pain, and well-being. Practical protocols (e.g., awe walks) offer clinicians scalable tools to augment care, while insights on social bonding (embarrassment/teasing) and carefully supervised psychedelic-assisted therapy highlight additional pathways to strengthen connection and resilience. Note: Some findings (e.g., long COVID improvements from brief daily awe) are preliminary and require further peer-reviewed validation.
Key Takeaways
Awe is a measurable, health-relevant state linked to increased vagal tone (HRV), reduced inflammation, lower physical pain, and reported improvement in long COVID symptoms from brief daily awe practices.
Shifting perceptual “aperture” from small to vast (for example, moving from focusing on a leaf to the canopy to the sky/horizon) reliably evokes awe and can recalibrate arousal, time perception, and self-focus toward equanimity.
An 8-week, once-weekly 20–30 minute “awe walk” intervention in older adults increased awe, kindness, and vast attention in daily life and reduced bodily pain, with longer-term follow-up suggesting brain health benefits.
Group synchrony (music, sport, dance, chanting, shared rituals) rapidly fosters bonding and collective identity, consistent with the concept of collective effervescence; embarrassment and prosocial teasing within groups signal commitment to norms and strengthen cohesion.
Psychedelics (classic serotonergic agents) can induce profound awe and may aid treatment-resistant conditions (e.g., end-of-life anxiety, depression, PTSD) when used in structured, safe, culturally respectful settings; microdosing lacks strong clinical evidence.
Clinical Insight
Awe can be deliberately elicited (nature, music, horizons, group synchrony) and functions as a low-cost, low-risk adjunct that measurably improves autonomic balance (vagal tone), reduces inflammatory load and pain, and supports mental health—making it a viable element to integrate into preventive care and rehabilitation plans.
Actionable Takeaway
Prescribe a weekly 20–30 minute awe walk for 8 weeks: ask patients to slow their pace and breath (prolonged exhalations), and to move attention from small to vast (e.g., a leaf → tree → treeline → clouds/horizon). Encourage one brief daily “micro-awe” (≈60 seconds via nature, music, or vistas). Track simple outcomes (pain ratings, mood/sleep, HRV if available) and consider adding music- or nature-based sessions for reinforcement.
6. Huberman Lab
Essentials: The Biology of Aggression, Mating & Arousal | Dr. David Anderson
Published: 2026-04-09
URL: Listen Here
Summary
This episode reviews the neurobiology of internal states governing aggression, mating, and arousal, emphasizing hypothalamic circuit logic, hormone signaling (notably estrogen pathways), and brain–body interactions. It highlights how social isolation engages conserved tachykinin mechanisms that amplify aggression and anxiety, suggesting concrete translational avenues (e.g., NK3 antagonists) while underscoring the clinical need to assess and address isolation.
Key Takeaways
Emotions are best understood as internal brain states (like arousal or motivation) that reshape input–output transformations of neural circuits; unlike reflexes, they often persist beyond the trigger and generalize across contexts.
Aggression is a heterogeneous set of behaviors supported by distinct but adjacent hypothalamic circuits (VMHvl): fear-related neurons can hierarchically suppress offensive aggression, and VMH integrates multisensory inputs while broadcasting low-dimensional ‘attack pressure’ signals widely.
Sex hormones do not map simply onto behavior: estrogen receptor–expressing neurons in male VMH are necessary for aggression, many testosterone effects are mediated via aromatization to estrogen, and in females, discrete VMH ER+ neuron subsets differentially control mating versus fighting.
Mating and aggression circuits exhibit reciprocal control: activating medial preoptic area (MPOA) ‘mating’ neurons can abruptly switch a male from fighting to courtship, whereas VMHvl ‘aggression’ neurons bias toward attack; PAG acts as a downstream ‘switchboard’ coordinating pain modulation and innate action patterns.
Social isolation robustly upregulates tachykinin signaling (e.g., tachykinin 2) across species, increasing aggression, fear, and anxiety; in mice, an NK3 receptor antagonist (osanotont) reverses isolation-induced phenotypes without sedation, highlighting a translational target for isolation-related psychopathology.
Clinical Insight
Social isolation is a potent, biologically mediated driver of negative affect and aggression—partly via tachykinin 2 signaling—with preclinical evidence that NK3 receptor antagonism can normalize isolation-induced aggression, fear, and anxiety without sedation; clinicians should treat isolation as a modifiable risk factor rather than a benign social state.
Actionable Takeaway
Routinely screen patients for social isolation (e.g., recent bereavement, living alone, limited social contact) and implement mitigation strategies—structured social engagement, therapy referrals, family/caregiver involvement, and follow-up touchpoints—especially in individuals showing increased irritability, anxiety, or aggression.
7. Huberman Lab
Essentials: The Biology of Aggression, Mating & Arousal | Dr. David Anderson
Published: 2026-04-09
URL: Listen Here
Summary
This episode synthesizes neural circuit, hormonal, and neuropeptide mechanisms underlying aggression, mating, arousal, and pain modulation. Key themes include hypothalamic control of offensive aggression and its suppression by fear, estrogenic regulation of male aggression, sex-specific VMH circuits for mating vs fighting, and tachykinin-driven effects of social isolation that are reversible with NK3R antagonism—findings with clear translational relevance for stress-related behavioral health.
Key Takeaways
Emotions are best understood as internal brain states (like arousal, motivation, sleep) that transform how inputs map to outputs; compared to reflexes, emotion states show persistence and generalization beyond the initial trigger.
Aggression is a behavior that can arise from different internal states (e.g., anger, fear, hunger); in mice, ventromedial hypothalamus (VMHvl) circuits drive offensive, positively valenced aggression, while adjacent hypothalamic fear circuits can hierarchically suppress fighting.
Hormonal control of aggression in males depends critically on estrogen receptor–expressing VMH neurons and aromatization of testosterone to estrogen; estrogen implants can restore aggression in castrated male mice.
Sex-specific neural architecture shapes behavior: in females, distinct estrogen receptor–positive VMH subsets separately control mating and fighting, and medial preoptic area (MPOA) ‘mating’ neurons can acutely suppress ongoing aggression (antagonistic VMH–MPOA interactions).
Social isolation upregulates tachykinin signaling (Tac2/neurokinin B) across the brain to increase aggression, fear, and anxiety; an NK3 receptor antagonist (osanetant) reverses these effects in mice. The periaqueductal gray (PAG) acts as a hub for innate behaviors and supports endogenous, state-dependent analgesia (e.g., during fear/defense).
Clinical Insight
Chronic social isolation induces a Tac2/NK3R-mediated, druggable brain state that heightens aggression, fear, and anxiety—highlighting both the clinical importance of assessing isolation/bereavement and the translational potential of NK3 receptor antagonism for stress-related behavioral dysregulation.
Actionable Takeaway
Routinely screen patients experiencing prolonged social isolation or bereavement for irritability, aggression, and anxiety, and implement structured social reconnection strategies (e.g., group therapy, regular follow-ups, community engagement) to mitigate these biologically primed risk states.
8. The Human Upgrade: Biohacking for Longevity & Performance
Why Doctors Can’t Fix Women in 2026 : 1446
Published: 2026-04-09
URL: Listen Here
Summary
This episode argues that modern care under-treats women’s hormones and that personalized, bioidentical HRT—especially estradiol and progesterone delivered vaginally at systemic doses—can be a cornerstone for restoring libido, cognition, mood, sleep, gut/gallbladder function, and overall vitality. The guests emphasize treating to clinical response (not just numbers), considering genetics and neurotransmitters, and leveraging nutrition (adequate protein, cautious fiber, iodine) while using testosterone judiciously. Note: Many claims were experiential and not directly cited; sponsor content and controversial viewpoints are included.
Key Takeaways
Personalized, bioidentical hormone replacement (estradiol, progesterone, ± testosterone) is presented as foundational for many symptomatic women—even premenopausally—with dosing guided by symptoms and function rather than fixed lab ‘norms’ or low-dose patches/pills.
Systemic vaginal delivery of estradiol and progesterone is advocated as higher bioavailability than oral/topical/patch routes, aiming to suppress elevated FSH and improve cognition, sleep, mood, gut/gallbladder function, and sexual function; oral progesterone’s sedating effects may arise from liver-derived metabolites.
Testosterone can benefit women’s libido and cognition but excess transdermal/injected T may increase DHT/aromatization or disrupt the vaginal microbiome; many women may normalize T by optimizing progesterone, with optional low-dose topical T for event-based arousal.
Diet and environment meaningfully influence hormones and neurotransmitters: prioritize adequate protein (supporting dopamine/COMT), avoid excessive insoluble fiber and certain phytoestrogens, consider iodine repletion for breast/uterine health, and be mindful of high-oxalate foods (e.g., matcha/spinach) implicated in kidney stones and tissue symptoms.
Evaluate and treat holistically: use FSH and symptom clusters to detect early dysfunction, recognize genetic/epigenetic differences (e.g., COMT) in hormone clearance, consider neurotransmitter support (dopamine/norepinephrine/serotonin), and avoid focusing on thyroid alone when sex-hormone deficits drive multi-system complaints.
Clinical Insight
For women with multi-system symptoms (mood, sleep, gut, libido, cognitive), adequately dosed, bioidentical estradiol plus progesterone—preferably via systemic vaginal delivery—and personalized titration to clinical response can restore function across brain, immune, gut, and sexual domains; labs (including FSH) inform but should not replace symptom-guided care.
Actionable Takeaway
In an appropriate symptomatic woman (even <45), obtain FSH, estradiol, progesterone, total/free testosterone, SHBG, DHEA-S, and thyroid panel; if findings and history suggest ovarian under-function, initiate a trial of bioidentical estradiol + progesterone via systemic vaginal delivery and titrate every 6–8 weeks to symptom relief while reinforcing adequate protein intake and avoiding excessive insoluble fiber.
9. The Human Upgrade: Biohacking for Longevity & Performance
Superhuman Contact Lenses, Motivation Supplement Stack, Cat Scratches Cause Brain Fog, Amino Acid Shortening Lifespan, and more... : 1448
Published: 2026-04-10
URL: Listen Here
Summary
This episode highlights overlooked inputs—stealth infections, amino acid balance, sensory light processing, micronutrient status, and olfactory cues—that materially affect cognition, motivation, and autonomic tone. It offers practical steps clinicians can use now: targeted PCR testing for Bartonella, judicious lab monitoring around tyrosine, nutrient stacking to bolster motivation, and low-cost sensory strategies to reduce cognitive and stress load.
Key Takeaways
Cat scratches/bites can transmit Bartonella, a stealth infection linked to chronic brain fog, mood instability, and fatigue; standard serology often misses it—PCR testing is preferred and may require referral to a Lyme-literate clinician.
A Mendelian randomization analysis (~270,000 participants) associates higher circulating tyrosine with nearly one year shorter lifespan in men (not women), potentially via myeloperoxidase-driven formation of inflammatory meta-tyrosine; consider measuring plasma tyrosine and phenylalanine and avoiding unnecessary tyrosine supplementation, especially in men.
Tinted contact lenses (Altius) reportedly reduce chromatic aberration by 53% and improve contrast by 20–30%, potentially lowering visual processing load and enhancing performance; spectrum-filtering eyewear (e.g., TrueDark) and screen apps (Flux/Iris) are adjuncts.
A randomized, placebo-controlled crossover trial from the University of the Philippines found a 4-week stack (taurine 2 g, methylfolate 800 mcg, P5P 50 mg, methylcobalamin 1 mg) increased effort-based motivation and reduced attention lapses, plausibly via astrocytic glutathione support of prefrontal function.
A Monell Chemical Senses Center analysis indicates a 30-second deep nasal inhalation of floral scents can lower heart rate by 5–10 bpm and shift autonomic tone toward parasympathetic; lavender has the strongest RCT support, but pleasant florals broadly appear effective.
Clinical Insight
In patients with persistent neurocognitive or mood symptoms and a history of cat scratches/bites, Bartonella infection is likely underrecognized; order a Bartonella PCR (not just serology) and consider referral to a tick-borne disease–literate clinician, as antibody tests can miss intracellular, tissue-resident infections.
Actionable Takeaway
For patients (especially men) using tyrosine-containing supplements or very high-protein diets, obtain a fasting plasma tyrosine and phenylalanine panel (Quest/LabCorp) and review inflammatory markers; avoid or reduce tyrosine supplementation if levels are high or the tyrosine:phenylalanine ratio approaches/exceeds 10:1.
10. The Human Upgrade: Biohacking for Longevity & Performance
CDC Director Jim O’Neill on Fixing America’s Broken Food Policy : 1449
Published: 2026-04-14
URL: Listen Here
Summary
This episode features Jim O’Neill outlining an HHS/CDC push to overhaul U.S. food guidance and aging research while refocusing CDC on infectious diseases. Highlights include whole‑food, higher‑protein dietary guidance with forthcoming RCTs on saturated fat, large ARPA‑H investments in causal aging biomarkers and organ bioprinting, and greater openness to AI, wearables, non‑pharma therapies, and GLP‑1s. Several claims are policy announcements or opinions presented without primary citations.
Key Takeaways
The guest describes newly released federal dietary guidelines that emphasize whole and minimally processed foods, higher protein intake (1.2–1.6 g/kg/day), and allow meat and full‑fat dairy, while de-emphasizing refined grains and ultra‑processed foods; randomized controlled trials on saturated fats are being initiated.
HHS is prioritizing rigorous replication and aging science, including a reported $144M ARPA‑H initiative to identify causal biomarkers of aging and an organ bioprinting program that has printed a pediatric heart/vasculature (not yet implanted).
CDC is being refocused on infectious diseases, with examples cited of assisting to contain Ebola (DRC) and Marburg (Ethiopia), alongside a stated goal of rebuilding public trust through transparency.
There is openness to evaluating non‑pharmaceutical interventions (e.g., ozone therapy) with the same standards as drugs, and to integrating AI and wearables into care and surveillance—paired with strong patient consent and privacy protections.
Clinical and policy notes include support for GLP‑1s in obesity treatment, an ongoing review of upper vitamin D limits, and improvements to school meals aligned with the updated guidelines.
Clinical Insight
A shift toward whole‑food, higher‑protein nutrition with a more individualized view of dietary fats suggests clinicians should reassess grain‑centric, low‑fat counseling and focus on reducing ultra‑processed carbohydrates while tailoring fat and protein recommendations to each patient’s metabolic risk and goals.
Actionable Takeaway
For adult patients—especially those with metabolic syndrome risk or sarcopenia—calculate and document an individualized daily protein target of 1.2–1.6 g/kg from whole‑food sources, pair this with counseling to minimize ultra‑processed/refined carbohydrates, and reassess lipid/metabolic labs to tailor fat recommendations.
11. Huberman Lab
How Women Can Improve Their Fertility & Hormone Health | Dr. Natalie Crawford
Published: 2026-04-13
URL: Listen Here
Summary
Dr. Crawford details a proactive, science‑based roadmap for improving female fertility and hormone health: use AMH and ovulation tracking to detect issues early, leverage high‑impact lifestyle changes and targeted supplements during the “trimester zero,” and apply appropriate medical tools without waiting for failure. She emphasizes avoiding cannabis and nicotine, practical contraception off‑ramp timing, and clarifies that egg freezing/IVF do not reduce ovarian reserve, while highlighting select promising but still investigational therapies. Note: Summary reflects the provided transcript and may omit topics discussed outside these excerpts.
Key Takeaways
Proactive fertility assessment matters: Anti-Müllerian Hormone (AMH) testing estimates ovarian reserve (not egg quality) and can guide life and treatment planning; it’s inexpensive (~$79) and useful even before trying to conceive.
Track ovulation, not just periods: A luteal phase <11 days is an early red flag for ovulatory dysfunction; avoid NSAIDs except during menses because they can block follicle rupture and ovulation.
Lifestyle and exposures strongly influence fertility and hormone health: Prioritize sleep (7–9 h), stress control, muscle building, anti-inflammatory nutrition, and toxin minimization; avoid cannabis and nicotine (both sexes), which impair gametes and increase miscarriage risk.
Evidence-supported preconception supplements: Begin a prenatal (with folate), CoQ10, omega-3 fatty acids, and vitamin D; for male partners, add L‑carnitine (± zinc/selenium). Consider low-dose melatonin (1–3 mg) for sleep/inflammation preconception, then stop in pregnancy.
Clinical nuances: Egg freezing/IVF do not deplete ovarian reserve; stop combined OCPs 3–6 months before trying to learn ovulation, remove levonorgestrel IUD ~6 months before attempting conception, and avoid Depo‑Provera if planning pregnancy within 1–2 years. Selective, emerging tools (e.g., GLP‑1s in insulin resistance/inflammation, intrauterine PRP for implantation failure) show promise; ovarian PRP and red light remain investigational.
Clinical Insight
Replace the “fail‑first” model with an early, data‑driven approach: normalize AMH screening and ovulation/luteal‑phase tracking for reproductive‑age women to surface problems sooner and tailor timely lifestyle, medical, or procedural interventions that can materially improve outcomes.
Actionable Takeaway
At routine visits for women who might want children, offer AMH testing and brief ovulation‑tracking education, and initiate a 60–90‑day preconception plan: sleep 7–9 h; avoid cannabis/nicotine and NSAIDs outside menses; start prenatal (folate), CoQ10 (200–400 mg/day), omega‑3 (1–2 g/day EPA+DHA), vitamin D per level; counsel partners to add L‑carnitine (≈2 g/day); reassess promptly if luteal phase <11 days, cycles irregular, age ≥35, or ≥2 pregnancy losses.
12. The Human Upgrade: Biohacking for Longevity & Performance
CDC Director Jim O’Neill on Fixing America’s Broken Food Policy : 1449
Published: 2026-04-14
URL: Listen Here
Summary
Acting CDC Director Jim O’Neill outlines a pivot in U.S. food policy toward whole foods and away from ultra‑processed, grain‑heavy patterns, alongside active trials reassessing saturated fats. He details federal investments in causal aging biomarkers via ARPA‑H, broader acceptance of AI and wearables (with consent) in care, a renewed CDC focus on infectious diseases, support for GLP‑1s in obesity management, and a review of vitamin D limits. Several points reflect evolving policy announcements described in the interview.
Key Takeaways
HHS/CDC leadership reports newly announced U.S. dietary guidelines that emphasize whole, minimally processed foods, reduce reliance on grains and ultra-processed foods, and affirm that meat and full‑fat dairy can fit into a healthy diet; randomized controlled trials on saturated fats are underway.
The government is prioritizing replication and rigor, including a $144M ARPA-H initiative to develop and FDA‑validate causal biomarkers of aging to enable surrogate endpoints for prevention and longevity therapies.
CDC is refocusing on infectious disease and highlights recent collaborations that contained Ebola (DRC) and Marburg (Ethiopia), while rebuilding public trust via transparency and focus.
There is openness to testing non‑pharmaceutical and biohacking innovations (e.g., ozone therapy) with the same scientific standards, and expanded use of wearables and AI for early detection and clinical decision support, with strong emphasis on privacy and informed consent.
GLP‑1 receptor agonists are supported as effective tools for obesity when paired with nutrition and fitness, vitamin D upper‑limit recommendations are under review, and school meals are viewed as a high‑leverage point for improving national nutrition.
Clinical Insight
Expect a policy shift in federal nutrition guidance—toward whole, minimally processed foods with adequate protein and without blanket avoidance of saturated fat/full‑fat dairy—which, combined with GLP‑1 use where appropriate, can reshape counseling and management of obesity and cardiometabolic disease.
Actionable Takeaway
Update nutrition counseling now: guide patients to prioritize whole foods and minimize ultra‑processed/refined grains, target 1.2–1.6 g/kg/day protein, individualize recommendations on saturated fat based on cardiometabolic risk, and routinely measure 25‑OH vitamin D with supplementation as needed under monitoring.
13. The Human Upgrade: Biohacking for Longevity & Performance
1 Cup Every Morning Helped Me Lose 100 Pounds (Drink THIS) : 1452
Published: 2026-04-19
URL: Listen Here
Summary
This episode is a first‑person narrative promoting butter/MCT coffee, intermittent fasting, and a high‑fat, low‑grain approach while labeling common nutrition beliefs as myths and de‑emphasizing exercise for fat loss. It reflects popular biohacking perspectives but provides limited primary evidence; clinicians may encounter patients adopting these strategies and should contextualize them within current guidelines and individualized risk assessment.
Key Takeaways
Host Dave Asprey attributes losing over 100 pounds to starting mornings with “butter coffee” (grass‑fed butter + MCT oil) and practicing intermittent fasting, emphasizing satiety, steady energy, and reduced cravings.
He presents nine “myths” he believes hinder weight loss: saturated fat is harmful; low‑fat diets are healthy; calories‑in/calories‑out drives weight change; frequent small meals boost metabolism; all vegetables are beneficial (citing anti‑nutrients in some); whole grains are healthy; fruit is universally healthy (warns about fructose); breakfast is essential; and exercise is the primary tool for fat loss.
Asprey advocates prioritizing saturated fats from grass‑fed animal sources and coconut oil, avoiding trans fats and processed seed/vegetable oils, minimizing grains and high‑fructose fruits, and selecting lower anti‑nutrient vegetables.
He claims mold/mycotoxins in some coffees drive jitters and poorer tolerance, recommending “clean” coffee; he also argues diet quality and fasting outweigh exercise for fat loss and warns that overtraining may elevate cortisol.
The episode is largely anecdotal and promotional, referencing his books and commercial products; specific primary research citations supporting many claims are not provided.
Clinical Insight
Patients may inquire about high‑fat morning beverages and time‑restricted eating to curb hunger and aid weight management; clinicians should individualize guidance and, if trialed, monitor cardiometabolic risk (e.g., LDL‑C/apoB, glycemia, liver enzymes) given that several assertions—especially high saturated fat intake and broad avoidance of plant foods/grains—diverge from prevailing evidence‑based guidelines.
Actionable Takeaway
When patients ask about “butter coffee” or intermittent fasting, offer a short, supervised 2–4 week trial of time‑restricted eating (e.g., 14–16 hour daily fast) focused on minimally processed foods; advise non‑caloric morning beverages in higher‑risk patients, track hunger/weight/glucose, and recheck lipids as indicated before making longer‑term changes.
14. The Human Upgrade: Biohacking for Longevity & Performance
Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453
Published: 2026-04-21
URL: Listen Here
Summary
Jason Fung contends that contemporary obesity is driven primarily by hedonic and conditioned hunger magnified by ultra-processed foods and pervasive eating cues, not by a simple excess of calories. He outlines three rules—ditch ultra-processed foods, reintroduce fasting windows, and engineer environments—to lower hunger and make weight loss sustainable, positioning GLP‑1 medications as appetite-lowering tools to use alongside real‑food and behavior change.
Key Takeaways
Hunger has three distinct drivers—homeostatic (physical), hedonic (pleasure), and conditioned (cue-driven/social)—and the latter two dominate modern overeating.
Ultra-processed foods are engineered to maximize reward and minimize satiety (rapid absorption, texture modifiers, emulsifiers, flavor enhancers), amplifying hedonic and conditioned hunger independent of calories.
Sustained weight loss rarely results from calorie restriction alone; approaches that reduce hunger (diet quality, meal timing/fasting, environmental redesign) work better. GLP-1 receptor agonists help mainly by suppressing appetite but require concurrent habit change for durability.
Fung’s three golden rules: eliminate ultra-processed foods; include consistent fasting periods (reduce meal frequency/snacking); and redesign schedules/environments to remove eating cues and food noise.
Behavioral and mindset tools—such as extinction and counter-conditioning, eating only at a table, and reframing ultra-processed items as “not food”—can deprogram conditioned hunger and reduce cravings.
Clinical Insight
For patients with obesity, target hunger biology and conditioned cues rather than caloric math: assess and modify diet quality (real food over ultra-processed), structure meal timing (fasting windows), and reshape social/environmental triggers; consider GLP-1 agents to reduce appetite while concurrently coaching durable nutrition and behavioral skills.
Actionable Takeaway
At the next visit, screen for the three hunger types and initiate a 4‑week protocol: eliminate ultra-processed foods; eat 2–3 real‑food meals within an 8–10‑hour window with no calories between; and remove eating cues (no eating in the car/TV, keep snacks out of sight). If on a GLP‑1, pair with nutrition/behavioral coaching to build lasting habits.
15. The Human Upgrade: Biohacking for Longevity & Performance
Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453
Published: 2026-04-21
URL: Listen Here
Summary
This episode reframes obesity care around managing hunger biology and learned cues rather than prescribing calorie restriction. Fung explains how ultra-processed foods and ubiquitous food cues amplify hedonic and conditioned hunger, and outlines three practical rules—cut UPFs, add fasting windows, and redesign environments—to align physiology and behavior. GLP-1 medications can help by suppressing hunger, but sustained success depends on concurrent nutrition and behavioral retraining.
Key Takeaways
Overeating is primarily a hunger problem—not a calorie problem—with three contributors: homeostatic (physical), hedonic (pleasure-driven), and conditioned (cue-driven) hunger; in modern environments, conditioned and hedonic hunger dominate.
Ultra-processed foods are engineered to maximize reward (rapid absorption, intense flavors, optimized texture) while minimizing satiety, reinforcing both hedonic and conditioned hunger and driving habitual overconsumption.
Calorie restriction alone fails long term because physiology adapts and hunger intensifies; focusing on reducing hunger signals via food quality, structured fasting, and behavioral strategies is more sustainable.
GLP-1 receptor agonists reduce hunger and can enable weight loss, but durable results require concurrent learning of real-food eating patterns and environment/cue redesign to prevent relapse when medications stop.
Dr. Fung’s three golden rules: (1) eliminate ultra-processed foods; (2) establish consistent fasting windows and stop constant snacking; (3) redesign schedules and environments to reduce food cues, using counterconditioning and extinction to retrain conditioned hunger.
Clinical Insight
For sustained weight loss, clinicians should target the biology and behavior of hunger—especially conditioned and hedonic drivers—by replacing ultra-processed foods with real foods, implementing time-based fasting windows, and modifying environments/cues; pharmacologic appetite suppression (e.g., GLP-1 RAs) can be an adjunct but must be paired with nutrition and behavior change to maintain results.
Actionable Takeaway
Start a two-week intervention: advise patients to remove ultra-processed foods from home/work, eat 2–3 whole-food meals daily with adequate protein and natural fats, avoid between-meal snacks, and keep a 12–14-hour overnight fast; restrict eating to a table (not cars/TV) and replace evening snacking with unsweetened tea to extinguish conditioned cues, then reassess hunger/craving patterns at follow-up.
16. The Human Upgrade: Biohacking for Longevity & Performance
Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453
Published: 2026-04-21
URL: Listen Here
Summary
Dr. Jason Fung reframes weight loss around hunger biology and environment, arguing that hedonic and conditioned hunger—amplified by ultra-processed foods and pervasive cues—drive overeating more than true physical hunger. Sustainable management targets appetite regulation (real food, fasting windows, environment design, behavioral techniques) and may incorporate GLP-1 therapy as a tool while patients build lasting dietary and behavioral skills.
Key Takeaways
Obesity is driven by three types of hunger—homeostatic (physical), hedonic (pleasure-driven), and conditioned (social/cue-driven)—with conditioned and hedonic hunger now dominating due to environment, marketing, and constant food cues.
Chronic calorie restriction fails long-term because appetite and hormones (e.g., insulin, GLP-1 pathways) govern intake and expenditure; GLP-1 receptor agonists work by lowering hunger but require concurrent nutrition and behavior change for durable results.
Ultra-processed foods (UPFs) are engineered to maximize reward (rapid absorption, flavor enhancers, emulsifiers/texturizers) and minimize satiety, amplifying ‘food noise,’ cravings, and overeating; additives like carrageenan/xanthan gum can worsen mouthfeel-driven intake and may irritate the gut.
Fung’s three golden rules: (1) eliminate UPFs in favor of real, nutrient-dense foods; (2) ensure an adequate fasting window and stop constant snacking; (3) redesign schedule and environment (eat at a table, avoid eating while driving/TV, manage cues) to reduce conditioned hunger.
Behavioral strategies such as counterconditioning (pairing cravings with aversive imagery) and extinction/substitution (e.g., tea instead of snacks while watching TV), plus a mindset shift to view UPFs as “not food,” help deprogram conditioned eating.
Clinical Insight
Effective obesity care centers on diagnosing and treating hunger dysregulation (hedonic and conditioned drivers) and hormonal responses to food, not prescribing simple calorie restriction; prioritize removal of ultra-processed foods, structured fasting/eating windows, and environmental cue control, using GLP-1s as adjuncts to reduce hunger while patients learn durable eating behaviors.
Actionable Takeaway
Start a 2–4 week ‘real food + fasting’ trial: remove all ultra-processed items and sweetened/‘diet’ beverages; eat 2–3 real-food meals daily emphasizing protein and natural fats; maintain a 12–16 hour overnight fast with no snacking; and restrict eating to a table—then reassess hunger, satiety, and weight at follow-up.
17. The Human Upgrade: Biohacking for Longevity & Performance
Inside Kambo: Poison, Purging, and The People Who Swear By It : 1455
Published: 2026-04-24
URL: Listen Here
Summary
This episode examines Kambo’s traditional origins, modern ceremonial use, administration, peptide-based mechanisms, safety profile, and preliminary human outcomes. It highlights practical risk-reduction (especially electrolyte management), underscores the paucity of rigorous clinical data, and discusses sustainability and training standards relevant to clinicians advising patients exploring Kambo.
Key Takeaways
Kambo (frog skin secretion from Phyllomedusa bicolor) is applied via superficial skin burns and is not a classical psychedelic; it induces a rapid, intense 20–30 minute experience marked by flushing, tachycardia, nausea/vomiting, sweating, shaking, transient facial swelling (“frog face”), and possible bowel movements or syncope.
Traditional Amazonian use centered on ‘hunting magic’ (adaptogenic effects like heightened perception and stamina); modern practice emphasizes ritual, trauma work, and broad wellness aims, with anecdotal utility reported for pain, autoimmune issues, infections, metabolic disease, and addiction.
Pharmacology involves at least 27 peptide analogs across eight families (e.g., opioid-receptor–active and vagal-acting peptides, antimicrobial peptides) producing vascular, GI, autonomic, and possible antipsychotic effects; however, rigorous human research on the full Kambo cocktail is sparse.
Safety hinges on preventing hyponatremia from overhydration (especially when stacked with low-salt ayahuasca dieta/fasting) and supervising to mitigate aspiration and falls; with careful screening, electrolyte management, and close monitoring, serious adverse events appear uncommon.
Emerging data (practice datasets, a post-session survey, and a prospective human study pending publication) suggest improvements in mood, mindfulness, happiness, pain, and fatigue after Kambo; sustainability and standardization remain challenges, spurring conservation work and attempts to characterize/synthesize peptide mixtures.
Clinical Insight
Kambo is a peptide-rich, non-psychedelic intervention with meaningful autonomic, GI, antimicrobial, and opioid-receptor effects that may yield short-term improvements in mood, mindfulness, and pain—yet its safe application in practice depends primarily on rigorous screening and proactive electrolyte management to prevent hyponatremia.
Actionable Takeaway
If a patient plans to undergo Kambo, counsel them to avoid overhydration: use salted fluids or oral electrolyte solution (e.g., add 1/4–1/2 tsp sea salt per liter of water), avoid low-salt/fasting protocols and stacking with ayahuasca within 24–48 hours, and ensure the session is supervised by a trained practitioner who monitors for syncope/aspiration.
18. Huberman Lab
Male Roles, Obligations and Options for Building a Fulfilling Life | Scott Galloway
Published: 2026-04-27
URL: Listen Here
Summary
This episode examines modern male roles and well-being, advancing a positive masculinity framework (provider–protector–procreator plus service) and concrete habits that build purpose, skills, and relationships. It highlights Big Tech’s role in compulsive use and isolation, advocates for mentorship and national service, and outlines policy levers (antitrust, algorithmic liability, age-gating) and personal behaviors clinicians can reinforce to improve mental health and social outcomes.
Key Takeaways
Galloway proposes a constructive masculinity code—provider, protector, procreator—augmented by service and the goal of creating “surplus value” (giving more than one takes).
Practical plan for struggling young men: reclaim screen time; train hard (≥3x/week); work outside the home (~30 hrs/week when feasible); engage weekly in team/service groups; and practice graded social “approaches,” embracing rejection as a skill-builder.
Big Tech and algorithmic feeds foster compulsive phone use, isolation, and polarization; policy remedies discussed include antitrust actions, algorithmic liability (Section 230 reform), and age-gating social media for minors.
Male mentorship and (ideally) national service are framed as high-yield solutions to purpose, skill development, and social cohesion—especially critical for boys lacking an involved male role model.
Societal/economic context matters: wealth transfer from young to old, higher-ed gatekeeping, and limited vocational on-ramps are linked to male underachievement and relationship/fertility headwinds; clinicians should recognize porn overuse as an under-researched, potentially demotivating behavior, while alcohol/THC can be net harmful or helpful depending on context and use patterns.
Clinical Insight
For young and midlife men, social isolation coupled with compulsive digital use (better conceptualized as an OCD-like compulsion loop than simple ‘dopamine hits’) is a potent driver of anxiety, depression, and suicidality; brief clinical screening and counseling that redirect time toward structured exercise, out-of-home work/school, service/mentorship, and graded real-world social engagement can meaningfully improve mental health and functioning.
Actionable Takeaway
In visits with adolescent and young adult males, add a 4-point screen—1) daily screen time and app limits, 2) exercise ≥3 days/week (resistance and/or endurance), 3) hours spent working or studying outside the home, 4) weekly group/service participation—then prescribe a 2–4 week trial to reallocate at least 8 hours/week from phone use to those activities and provide a mentorship or Big Brothers Big Sisters referral if a stable male role model is lacking.
19. The Human Upgrade: Biohacking for Longevity & Performance
The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458
Published: 2026-04-30
URL: Listen Here
Summary
This episode outlines how EWOT and red/near-infrared light therapy can be mechanistically complementary: exercise-driven hyperoxia improves oxygen delivery while PBM increases mitochondrial oxygen demand and nitric oxide–mediated microvascular perfusion. The approach targets endothelial and mitochondrial dysfunction implicated in fatigue, chronic inflammation, and recovery limitations, with a practical protocol of 15 minutes of EWOT followed by immediate PBM. Few specific clinical trials were cited during the conversation; recommendations were largely mechanistic and experiential.
Key Takeaways
Exercise with Oxygen Therapy (EWOT) delivers ~93% oxygen during 10–15 minutes of light-to-moderate exercise using a concentrator and large reservoir bag, leveraging exercise-induced increases in ventilation, heart rate, vasodilation, and pressure gradients to drive oxygen deeper into tissues than resting oxygen supplementation.
Chronic inflammation and endothelial dysfunction impair microcirculation (pseudo-hypoxia) even when pulse oximetry is normal; swollen endothelial cells and less-flexible RBCs limit capillary oxygen delivery, pushing cells toward anaerobic metabolism, ROS production, and a self-reinforcing inflammatory loop.
Red/near-infrared photobiomodulation (PBM) enhances mitochondrial function by increasing oxygen demand and releasing nitric oxide for vasodilation; stacking PBM immediately after EWOT (when circulation and tissue oxygen levels are elevated) amplifies outcomes (energy, sleep, pain, recovery).
A practical stack advocated: ~15 minutes of EWOT followed immediately by 10–20 minutes of red/NIR light (multiple red and NIR wavelengths) targeted to symptomatic areas or whole body to pair oxygen supply with mitochondrial uptake.
Potential use cases discussed include fatigue, long-COVID/lung injury, endothelial and microvascular dysfunction, ‘anaerobic’ infections (e.g., Lyme), and detox support; the episode’s claims were primarily mechanistic and experiential, with few specific trials cited.
Clinical Insight
Tissue-level hypoxia from microvascular/endothelial dysfunction can persist despite normal SpO2; combining EWOT to enhance oxygen delivery with photobiomodulation to increase mitochondrial oxygen utilization and nitric oxide–mediated perfusion may help break cycles of low energy, inflammation, and impaired recovery.
Actionable Takeaway
For appropriate patients, trial a stacked protocol: 10–15 minutes of moderate EWOT (reservoir-fed ~93% FiO2) followed immediately by 10–15 minutes of red/NIR photobiomodulation (e.g., 620–660 nm and 800–1050 nm) targeted to key regions (e.g., lungs, neck/shoulders, lower limbs), while monitoring HR/BP/SpO2 and tracking functional markers (symptoms, 6MWT/VO2 proxy, and if available pulse wave velocity). Screen for contraindications to high FiO2 and follow oxygen safety protocols.
20. The Human Upgrade: Biohacking for Longevity & Performance
The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458
Published: 2026-04-30
URL: Listen Here
Summary
This episode explores how EWOT and red/near-infrared light target complementary sides of cellular energetics: EWOT boosts oxygen delivery during exercise, while photobiomodulation increases mitochondrial oxygen use and nitric oxide signaling. By addressing endothelial/microcirculatory dysfunction and mitochondrial inefficiency—common in aging and chronic disease—the combined approach may enhance energy, recovery, and vascular health, with practical protocols feasible at home.
Key Takeaways
Exercise with Oxygen Therapy (EWOT) uses a concentrator and large reservoir to deliver ~93% oxygen during 15 minutes of moderate exercise, leveraging exercise-induced vasodilation and pressure gradients to drive oxygen deeper into hypoxic tissues.
Aging and chronic illness often feature microcirculatory dysfunction and endothelial swelling that block red blood cells from reaching capillaries, creating tissue-level “pseudo-hypoxia” despite normal pulse oximetry; mitochondria then shift to low-yield anaerobic metabolism with more inflammatory byproducts.
Red/near-infrared light (photobiomodulation) complements EWOT by increasing mitochondrial oxygen demand and efficiency (e.g., cytochrome c oxidase effects) and by promoting nitric oxide–mediated vasodilation, improving energy production and microvascular function.
Stacking protocol: complete a 15-minute EWOT session, then immediately apply red/near-IR light (10–15 minutes) to capitalize on elevated circulation and oxygen availability; simultaneous use is possible but less practical.
Discussed benefits include improved energy, sleep, pain, skin quality, recovery, and potential support in conditions with microvascular/mitochondrial dysfunction (e.g., Lyme, post-viral/long-COVID lungs), along with practical access to home EWOT systems and broad-spectrum red/IR devices.
Clinical Insight
Tissue hypoxia from microvascular and endothelial dysfunction can persist with normal SpO2 and underlies many chronic symptoms; combining strategies that enhance oxygen delivery (EWOT) with those that increase mitochondrial oxygen utilization and nitric oxide–driven vasodilation (red/near-IR light) may restore cellular energy and improve function in select patients.
Actionable Takeaway
For appropriately screened patients, implement a stack 3–5 times weekly: 15 minutes of EWOT at moderate exertion using a reservoir-fed concentrator (~93% O2), followed immediately by 10–15 minutes of red/near-IR photobiomodulation directed to priority regions (e.g., thorax for lung issues or large muscle groups); track response via symptoms (energy, sleep, pain) and, when available, vascular metrics (e.g., pulse wave velocity).
21. The Human Upgrade: Biohacking for Longevity & Performance
The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458
Published: 2026-04-30
URL: Listen Here
Summary
This episode explains how EWOT and red/near‑infrared light therapy can be combined to address mitochondrial dysfunction and microcirculatory ‘pseudo-hypoxia’ that underlie many chronic symptoms. The discussion emphasizes endothelial health, nitric oxide–mediated vasodilation, arterial stiffness (pulse wave velocity), and the lung’s role in detoxification, offering a practical sequencing strategy (EWOT, then PBM) to enhance energy, recovery, and tissue oxygenation. Limitations: the conversation is expert opinion–heavy and promotional in parts, and does not cite specific peer‑reviewed studies.
Key Takeaways
Exercise with oxygen therapy (EWOT) uses a concentrator and large reservoir (~93% O2) to deliver high oxygen flow during 10–15 minutes of moderate exercise, leveraging exercise-induced vasodilation and pressure gradients to drive oxygen deeper into tissues.
Stacking red/near-infrared photobiomodulation (PBM) immediately after EWOT exploits elevated circulation and oxygen availability to increase mitochondrial oxygen demand and efficiency, enhancing energy production, recovery, pain relief, and potentially sleep, skin, and sexual function via nitric oxide signaling.
Endothelial health and microcirculation are central: inflammation causes endothelial swelling and reduced RBC deformability, creating ‘pseudo-hypoxia’ (normal SpO2 but poor tissue oxygenation) that shifts mitochondria to inefficient anaerobic metabolism and a pro-inflammatory ‘doom loop.’
Arterial stiffness is an aging biomarker (e.g., pulse wave velocity); exercise and PBM can increase nitric oxide, improve vasodilation, and may support arterial flexibility and downstream tissue oxygenation.
Lungs are major detox organs (~70% of toxin elimination); adequate oxygen is required for biotransformation and repair. EWOT may support recovery in post-viral/lung injury states by improving cellular oxygenation and mitochondrial energy needed for healing.
Clinical Insight
Sequenced therapy—EWOT to rapidly elevate tissue oxygen supply followed immediately by PBM to raise mitochondrial oxygen demand—can help overcome tissue-level ‘pseudo-hypoxia,’ restore aerobic metabolism, and improve microcirculatory function in patients with chronic inflammation, endothelial dysfunction, or post-illness fatigue.
Actionable Takeaway
Implement a clinic protocol: 10–15 minutes of EWOT (reservoir-fed ~93% O2) at moderate intensity (elevated HR/respiratory rate) followed within 5 minutes by 10–20 minutes of PBM (combined red ~630–680 nm and near-infrared ~800–1050 nm) targeted to symptomatic regions (e.g., thorax for lung, large muscle groups, or generalized exposure). Monitor SpO2/HR/BP, start with conservative dosing, and track outcomes (e.g., 6MWT, symptom scores, VO2 max trend, pulse wave velocity/microvascular assessments). Screen for photosensitizing meds and cardio-pulmonary contraindications.
22. The Human Upgrade: Biohacking for Longevity & Performance
Eat These Foods + Spices for 8 Weeks To Get 3 Years Younger | Kara Fitzgerald : 1461
Published: 2026-05-05
URL: Listen Here
Summary
This episode highlights clinical and mechanistic evidence that diet rich in methyl donors and polyphenols—supported by foundational lifestyle practices—can reverse epigenetic age within weeks, with nutrients doing the ‘heavy lifting.’ It also explores the frontier of Yamanaka factor biology and PRC2-linked ‘programmatic’ aging, proposing that select polyphenols may partially mimic reprogramming effects. Limitations include multimodal design (potential confounding), reliance on specific clocks, and that ‘Yamanaka mimetic’ strategies are largely preclinical.
Key Takeaways
An 8-week randomized controlled dietary and lifestyle program emphasizing methyl-donor foods and polyphenol-rich ‘methylation adaptogens’ reduced biological age by over three years on the Horvath epigenetic clock in healthy middle-aged men; subsequent analysis suggested nutrients—especially dense polyphenols—were the primary drivers.
The protocol featured 7–11 cups/day of fruits, vegetables, herbs, and spices; methylation-supportive foods (e.g., leafy greens, eggs, beets, liver); and included meditation, sleep hygiene, and exercise, with the control group’s exercise likely making exercise effects a wash.
Polyphenols (e.g., EGCG from green tea; culinary herbs like rosemary, oregano, marjoram, thyme; and targeted options like urolithin A) may modulate gene expression and epigenetic marks; supplements can layer on top of diet for therapeutic dosing, though diet provides synergistic ‘information’ not captured by single compounds.
Emerging work on Yamanaka factors and polycomb repressive complex 2 (PRC2) suggests a ‘programmatic’ component of aging; early evidence indicates caloric restriction and potentially select polyphenols could act as ‘Yamanaka mimetics’ to nudge youthful epigenetic programs (largely preclinical at present).
First-generation clocks (e.g., Horvath) may capture aspects of programmatic aging; newer measures (e.g., DunedinPACE) are useful for tracking pace of aging. Case reports indicate women can also achieve meaningful bioage improvements with similar nutrition-forward protocols.
Clinical Insight
A targeted, food-first intervention emphasizing methyl-donor nutrients and high–polyphenol intake—augmented by basic lifestyle practices—can measurably and rapidly lower epigenetic age; in this cohort, the nutritional components appeared to account for most of the effect.
Actionable Takeaway
Implement an 8-week methylation-supportive nutrition plan (7–11 cups/day of diverse plants and polyphenol-rich herbs/spices; plus methyl donors like leafy greens, eggs, beets, and liver), alongside meditation and sleep hygiene; consider layering targeted polyphenol and metabolic supplements (e.g., EGCG, urolithin A, alpha‑ketoglutarate, sodium butyrate) as appropriate, and measure epigenetic age (e.g., Horvath/DunedinPACE) pre- and post-intervention to assess impact.
23. Huberman Lab
Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern
Published: 2026-05-07
URL: Listen Here
Summary
Dr. Casey Halpern outlines how compulsive behaviors arise from dysregulated cortico-striatal reward circuits and how neuromodulation—DBS, TMS, and MRgFUS—can be leveraged to treat refractory cases, with immediate efficacy in movement disorders and growing promise in psychiatry. The episode emphasizes personalized, symptom-evoked targeting and the integration of invasive recordings, noninvasive tools, and machine learning to advance precision therapies for OCD, addiction, and eating disorders.
Key Takeaways
Deep brain stimulation (DBS) and MR-guided focused ultrasound (MRgFUS) can precisely modulate small brain regions; DBS provides adjustable electrical therapy via implanted electrodes, while MRgFUS enables incisionless ablation—both are highly effective for tremor and are being explored for psychiatric indications.
Obsessive-compulsive disorder (OCD) involves dysregulation of cortico-striatal circuits, especially the ventral striatum/nucleus accumbens, which gate reward-seeking versus compulsive behaviors; similar circuitry underlies addiction and binge-eating.
First-line OCD treatments include SSRIs/tricyclics and exposure and response prevention (ERP) therapy; about 30% remain symptomatic, and in severe refractory cases, DBS or capsulotomy yields roughly 50% response rates but often with residual symptoms—highlighting the need for more precise, symptom-specific targeting.
Noninvasive neuromodulation is advancing: TMS is FDA-approved for depression, OCD, and nicotine addiction; MRgFUS is FDA-approved for essential tremor and tremor-dominant Parkinson’s disease, with research into modulatory ultrasound and blood–brain barrier opening; stereo-EEG (sEEG) is being leveraged to define better targets for psychiatric diseases.
Emerging approaches seek to detect and interrupt pathologic urges (e.g., craving/obsession cells) using intraoperative recordings, lab-based mood/craving provocation paradigms, and machine learning—aiming for closed-loop, personalized interventions; awareness helps less severe cases but is often insufficient for the most refractory patients.
Clinical Insight
Compulsive behaviors across OCD, addiction, and binge-eating share a core dysfunction in ventral striatal reward/limbic circuits (notably the nucleus accumbens); targeted and personalized circuit modulation—guided by symptom-evoked neural signatures—offers a path to improve outcomes beyond current ~50% response rates from conventional DBS/lesional approaches.
Actionable Takeaway
For patients with OCD who remain symptomatic after adequate SSRI/tricyclic trials and ERP, refer to a specialized neuromodulation center to evaluate FDA-cleared transcranial magnetic stimulation (TMS) for OCD and to discuss candidacy and expectations for investigational DBS/capsulotomy in severe, treatment-refractory cases.
24. Huberman Lab
Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern
Published: 2026-05-07
URL: Listen Here
Summary
This episode outlines how compulsive behaviors and OCD arise from dysregulated cortico–striatal–limbic circuits and how neuromodulation—from TMS to DBS and MRI-guided focused ultrasound—is being applied and refined to treat severe, refractory cases. It emphasizes circuit-specific targeting (e.g., ventral striatum/nucleus accumbens), closed-loop detection of craving/obsession signals, and the roles of ERP and pharmacotherapy as first-line treatments. Note: As an Essentials excerpt, procedural details and specific trial outcomes are summarized at a high level.
Key Takeaways
Deep brain stimulation (DBS) delivers targeted electrical stimulation via implanted leads; transient effects (e.g., brief laughter or panic) reveal proximity to limbic circuits and have informed psychiatric applications beyond movement disorders.
Obsessive-compulsive disorder (OCD) and related compulsive/impulsive syndromes involve hyperactive prefrontal/orbitofrontal regions and ventral striatal circuits (notably the nucleus accumbens) that gate reward and compulsion; circuit-informed targeting is central to therapy development.
First-line OCD care includes SSRIs or clomipramine (tricyclics) and exposure and response prevention (ERP); ~30% remain refractory, and current surgical options (DBS or capsulotomy) achieve about a 50% responder rate, with residual symptoms common.
Noninvasive neuromodulation is advancing: TMS is FDA-cleared for depression, OCD, and smoking cessation; MRI-guided focused ultrasound is FDA-approved for tremor and is being explored for modulatory (non-ablative) applications and potential psychiatric targets.
Closed-loop paradigms combining invasive recordings (e.g., stereo-EEG/DBS) with symptom or mood provocation can identify ‘craving/obsession’ signals (e.g., for binge eating) to personalize stimulation, while awareness-based therapies help many but often fail in the most severe, treatment-resistant cases.
Clinical Insight
Compulsive and impulsive disorders are circuit-based conditions of cortico–striatal–limbic networks; precise, and increasingly closed-loop, neuromodulation targeting the ventral striatum/nucleus accumbens can provide meaningful benefit for severe, treatment-resistant patients, while TMS offers an FDA-cleared, less invasive option for select indications.
Actionable Takeaway
Establish a referral pathway to a specialty center (functional neurosurgery/psychiatry) for patients with treatment-refractory OCD to discuss neuromodulation options—offer an FDA-cleared TMS trial first when available, and consider DBS or capsulotomy evaluation (or clinical trials) if nonresponsive.
25. The Human Upgrade: Biohacking for Longevity & Performance
Pandemic Fever Is BACK, Testosterone and Brain Tumors, Rabies, and Dog Flu : 1463
Published: 2026-05-08
URL: Listen Here
Summary
This episode synthesizes emerging signals in oncology and infectious disease: new data suggesting physiologic testosterone may restrain glioblastoma behavior, alongside multiple zoonotic threats (Influenza D, canine coronavirus HuPn-2018, Andes hantavirus) and a temporary disruption to U.S. rabies testing. The unifying message is proactive risk management—know patients’ biologic baselines (e.g., hormones), reinforce first-line defenses (mucosal immunity, sleep, stress), and act quickly when exposure windows are short (rabies, hantavirus).
Key Takeaways
NIH-funded Cleveland Clinic research reported that low testosterone may drive glioblastoma stemness and invasion, whereas restoring physiologic testosterone reduced tumor growth by ~38% and improved survival in models—challenging assumptions that lower androgens universally reduce cancer risk.
CDC has paused certain testing (including rabies), creating potential 1–2 week diagnostic delays; because rabies PEP is time-critical, suspected exposures warrant same-day ER initiation of prophylaxis without waiting for lab confirmation; ensure pets are vaccinated and consider pre-exposure prophylaxis when traveling to endemic regions.
A U.S. Supreme Court one-week stay preserved telehealth access to mifepristone pending rapid review; the legal reasoning could set precedents affecting FDA authority, telehealth, and access to therapies such as compounded peptides and bioidentical hormones.
University of Florida researchers highlighted two zoonotic risks: Influenza D circulating in U.S. cattle and a canine coronavirus (HuPn-2018) that has jumped to humans; no vaccines exist and population immunity is minimal—reassess raw milk risk and reduce close pet-lick exposure while strengthening mucosal immunity (sleep, stress control, vitamin D, zinc, fermented foods).
Andes hantavirus cases linked to a cruise ship off the Canary Islands underscore that this American strain can spread person-to-person and causes severe pulmonary syndrome with high case fatality; recognize early symptoms (fever, myalgias, abrupt fatigue) and pursue urgent evaluation after plausible exposure.
Clinical Insight
Maintaining normal physiologic testosterone may suppress glioblastoma aggressiveness by limiting tumor stemness and invasion, suggesting clinicians should consider comprehensive hormonal assessment—especially in men—when evaluating brain tumor biology and overall oncologic risk, while recognizing these are emerging data that do not alone warrant changes to standard cancer therapy without oncology guidance.
Actionable Takeaway
For any patient with a credible rabies exposure (e.g., bat contact, wild carnivore bite), initiate post-exposure prophylaxis immediately and do not wait for laboratory confirmation—verify current turnaround times at your state lab and proactively counsel patients traveling to endemic regions about pre-exposure vaccination and prompt care-seeking.
26. Huberman Lab
Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern
Published: 2026-05-07
URL: Listen Here
Summary
This episode reviews how neurosurgical and noninvasive neuromodulation tools can modulate cortico–striatal–limbic circuits driving compulsive and impulsive behaviors, with a focus on OCD, addiction, and binge eating. It emphasizes current standards (SSRIs/tricyclics and ERP), the limitations of outcomes in severe, refractory cases, and the promise of symptom-locked, circuit-guided targeting—potentially enabling future noninvasive, scalable treatments.
Key Takeaways
Deep brain stimulation (DBS) and MR-guided focused ultrasound (MRgFUS) can rapidly and powerfully modulate brain circuits; while established for tremor and Parkinson’s disease, these tools are being adapted to target limbic circuits implicated in compulsive and impulsive behaviors (e.g., OCD, addiction, binge eating).
OCD is best understood along a spectrum; first-line treatments include SSRIs/tricyclics and exposure and response prevention (ERP), yet ~30% remain refractory. For severe cases, DBS or capsulotomy yield about a 50% responder rate, often with residual symptoms—highlighting the need for more precise, symptom-locked targeting.
Compulsion and impulsivity share cortico-striatal-limbic circuitry (prefrontal/orbitofrontal cortex to basal ganglia/ventral striatum, especially nucleus accumbens) that gates reward seeking; identifying ‘craving/obsession-related’ neural signals intraoperatively and in lab paradigms is enabling symptom-specific neuromodulation.
Noninvasive neuromodulation is expanding: TMS is FDA-approved for depression, OCD, and nicotine addiction; MRgFUS is FDA-approved for tremor and is being explored for circuit modulation and blood–brain barrier opening. Stereo-EEG methods from epilepsy are informing circuit mapping for psychiatric indications to guide future noninvasive targets.
Improving patient awareness can help, but the most severe patients often remain refractory despite high awareness; combining rigorous circuit-guided neuromodulation with behavioral therapies and exploring AI/digital phenotyping to forecast high-risk states may provide scalable, clinically meaningful advances.
Clinical Insight
Compulsive and impulsive behaviors frequently arise from dysregulation within a shared cortico–striatal–limbic circuit—particularly the ventral striatum/nucleus accumbens—and targeted, symptom-linked neuromodulation (invasive now, potentially noninvasive later) can acutely alter these states, offering a path forward for patients with severe, treatment-resistant OCD and related conditions.
Actionable Takeaway
For patients with moderate-to-severe, treatment-resistant OCD (failed adequate SSRI/clomipramine trials and ERP), discuss risks/benefits and refer to a specialty center for consideration of neuromodulation—TMS (therapeutic and circuit-probing), DBS (e.g., ventral capsule/ventral striatum) or capsulotomy—and potential enrollment in circuit-mapping/SEEG-informed trials, while maintaining evidence-based behavioral therapy.
27. The Human Upgrade: Biohacking for Longevity & Performance
Pandemic Fever Is BACK, Testosterone and Brain Tumors, Rabies, and Dog Flu : 1463
Published: 2026-05-08
URL: Listen Here
Summary
This episode synthesizes timely health stories: a Cleveland Clinic/NIH report that normal testosterone may suppress glioblastoma stemness, a CDC testing pause that heightens urgency for immediate rabies PEP, legal moves affecting mifepristone telehealth access, and zoonotic threats from influenza D, canine coronavirus, and Andes hantavirus. The unifying theme is proactive risk management—optimizing hormonal and immune baselines and taking swift action after high-consequence exposures. Some details are host-reported and specific study links were not provided in-episode, which may limit independent verification.
Key Takeaways
NIH-funded Cleveland Clinic research reported that physiologic testosterone suppresses glioblastoma stemness and invasion; in models, restoring normal T reduced tumor growth by ~38% and improved survival—challenging the assumption that lower testosterone uniformly lowers cancer risk.
The CDC pause in rabies (and some other) testing is causing 1–2 week diagnostic delays; because post-exposure prophylaxis (PEP) must start promptly (≈10 days) and symptomatic rabies is nearly 100% fatal, suspected exposures warrant same-day ER care, with pets kept current on vaccines and travelers to endemic regions considering pre-exposure prophylaxis.
A temporary U.S. Supreme Court stay preserved mail/telehealth access to mifepristone pending further action—raising broader implications for courts influencing FDA-approved protocols and telehealth access across other therapies (e.g., compounded peptides, bioidentical hormones).
University of Florida researchers flagged two zoonotic risks: influenza D circulating in U.S. cattle and a canine coronavirus strain (CCoV-HuPn-2018) previously detected in humans; neither has established population immunity or vaccines, underscoring practical steps to bolster mucosal immunity and apply caution with raw milk and close pet contact (e.g., face-licking).
An outbreak of Andes hantavirus linked to a cruise near the Canary Islands highlights that this strain can spread person-to-person and causes severe HPS with high mortality; early symptoms (fever, myalgias, rapid-onset fatigue) after plausible exposure should prompt urgent evaluation and explicit hantavirus consideration.
Clinical Insight
Emerging evidence suggests hypogonadism may promote glioblastoma aggressiveness via androgen receptor signaling; in appropriate male patients, clinicians should assess total and free testosterone and avoid non-indicated androgen deprivation—coordinating closely with oncology before modifying cancer-related hormonal management.
Actionable Takeaway
For suspected rabies exposures (e.g., bat contact/bites), initiate CDC-recommended post-exposure prophylaxis immediately without waiting for laboratory confirmation, given current testing delays and the near-100% fatality once symptoms begin.
28. Huberman Lab
Essentials: Understanding & Controlling Aggression
Published: 2026-05-14
URL: Listen Here
Summary
This episode explains the neural circuitry of aggression, emphasizing VMHvl Esr1+ neurons and how aromatized estrogen, stress hormones, and photoperiod interact to gate aggressive behaviors. It reframes testosterone’s role, highlights rapid circuit-level switches between mating and attack, and offers practical strategies—light exposure, heat, selective supplementation—to modulate aggression. As an Essentials recap, some dosing specifics and full trial details are referenced from prior episodes or literature rather than provided exhaustively in-audio.
Key Takeaways
Aggression comprises distinct forms (reactive, proactive, indirect) and is generated by coordinated neural circuits—most critically estrogen receptor–expressing neurons in the ventromedial hypothalamus (VMHvl)—acting as fixed action patterns rather than isolated brain regions.
Testosterone does not directly cause aggression; its aromatization to estrogen within the brain activates VMHvl Esr1+ neurons to drive attack behaviors in both males and females.
Context strongly gates aggression: short photoperiods, elevated cortisol, and low serotonin increase the likelihood that estrogen will trigger aggression; long photoperiods (more daylight) mitigate this effect via changes in melatonin, dopamine, and stress hormones.
Optogenetic activation of VMHvl Esr1+ neurons can rapidly switch behavior (e.g., from mating to attack) and recruits downstream periaqueductal gray (PAG) circuits that organize motor patterns such as biting and limb striking.
Practical levers to reduce aggressive tendencies include lowering cortisol (morning sunlight exposure, sauna/hot baths; cautious, short-term ashwagandha) and, in ADHD, adjunct acetyl-L-carnitine has evidence for reducing aggressive/impulsive episodes in a randomized controlled trial.
Clinical Insight
Aggression propensity is a state-dependent output of hypothalamic circuits (VMHvl Esr1+), gated by steroid signaling and the stress–neurochemical milieu; assessing and modulating contextual factors—especially cortisol/photoperiod and serotonergic tone—can meaningfully alter aggressive behavior beyond simplistic attributions to testosterone or mood states.
Actionable Takeaway
Implement a structured morning light protocol for irritable or seasonally worsened aggression: advise 10–30 minutes of outdoor sunlight exposure within 1 hour of waking, daily for 2–4 weeks, to lower cortisol and shift neuromodulators toward reduced reactivity; reassess symptoms and add heat therapy (e.g., 20-minute sauna or hot bath sessions) as needed.
29. The Human Upgrade: Biohacking for Longevity & Performance
Semen Switch, Chewing Gum, Creatine Cheat, Cancer Plants, and Bedtime Risk : 1467
Published: 2026-05-15
URL: Listen Here
Summary
This episode reviews studies on creatine’s cognitive support under acute sleep loss, microplastic exposure from chewing gum, the cardiovascular risks of irregular bedtimes, plant alkaloid biosynthesis enabling anticancer drug discovery, and a reversible nonhormonal male contraceptive target. The unifying theme is that seemingly neutral habits or exposures can carry measurable biological effects, with particular clinical relevance for circadian consistency. Limitations: the transcript lacks formal citations and may contain transcription errors in compound or organism names; verify primary sources before changing practice.
Key Takeaways
A single moderate dose of creatine (~14 g) preserved up to ~12% more cognitive performance during 21 hours of sleep deprivation in a double-blind crossover trial; women and people with lower baseline brain creatine (e.g., vegetarians/vegans) appeared to benefit more.
Chewing gum (synthetic and products marketed as natural/plastic-free) shed hundreds to ~3,000 microplastic fragments per stick into saliva; detected polymers included polyethylene and polystyrene, highlighting a previously underrecognized exposure source.
Objectively measured irregular bedtimes combined with shorter sleep were associated with about double the risk of major cardiovascular events over a decade in a Finnish cohort, underscoring the clinical importance of sleep timing regularity.
UBC researchers mapped a chromosome-level genome and decoded the biosynthetic pathway for a rare spirooxindole alkaloid (Mitraphylene) implicated in anti-tumor and anti-inflammatory activity, enabling potential scalable bioproduction; this is an early-stage drug discovery lead, not a recommendation to use kratom or related supplements.
Cornell researchers demonstrated reversible, nonhormonal male contraception in mice by inhibiting the testis-specific protein BRDT with JQ1: spermatogenesis stopped during treatment and fertility recovered after cessation with healthy offspring; translational safety and long-term effects require further study.
Clinical Insight
Sleep regularity—not just duration—is a modifiable risk factor linked to major cardiovascular events; counseling patients to maintain consistent bedtimes should be incorporated into cardiovascular risk reduction strategies.
Actionable Takeaway
Ask patients to set and adhere to a fixed 90-minute bedtime window every day (including weekends) and reassess sleep timing variability after 4–8 weeks; for higher-risk individuals, consider actigraphy or validated wearable data to quantify and address irregularity.
30. The Human Upgrade: Biohacking for Longevity & Performance
Semen Switch, Chewing Gum, Creatine Cheat, Cancer Plants, and Bedtime Risk : 1467
Published: 2026-05-15
URL: Listen Here
Summary
This episode reviews new research spanning acute creatine use for sleep-deprivation resilience, unrecognized microplastic exposure from chewing gum, the cardiovascular risks of irregular sleep timing, plant-derived drug discovery via kratom alkaloid biosynthesis, and a reversible, non-hormonal target for male contraception. The themes emphasize measurable exposures and behaviors that affect health now (e.g., sleep regularity, microplastics) and pipeline advances likely to influence future oncology and reproductive therapeutics.
Key Takeaways
Acute creatine supplementation (~10–15 g monohydrate) preserved up to ~12% more cognitive performance during 21 hours of sleep deprivation in a double-blind crossover trial; benefits appeared greater in women and those with lower baseline brain creatine (e.g., vegetarians/vegans).
Chewing gum—both synthetic and products marketed as “natural” or “plastic-free”—shed hundreds to ~3,000 microplastic fragments per stick into saliva during chewing, adding a largely unrecognized exposure source.
Objectively measured irregular bedtimes combined with short sleep duration were associated with approximately double the risk of major cardiovascular events over a decade, underscoring circadian regularity as a modifiable risk factor.
UBC researchers mapped the genome of Mitragyna parvifolia and decoded the biosynthetic pathway for the alkaloid mitraphylline, enabling potential bioreactor-scale production; this is a drug discovery pipeline advance, not evidence that kratom treats cancer.
Pharmacologic inhibition of the testis-specific protein BRDT with JQ1 in mice produced a reversible, non-hormonal “on–off” switch for spermatogenesis, restoring fertility after treatment cessation and suggesting a viable target for male contraception.
Clinical Insight
Sleep timing regularity is an independent, modifiable cardiovascular risk factor: patients with highly irregular bedtimes and short sleep had roughly double the rate of major cardiovascular events when sleep timing was objectively measured, supporting routine assessment and counseling on circadian consistency.
Actionable Takeaway
Incorporate a brief sleep-timing screen (e.g., ask about bedtime variability and weekend ‘social jetlag’) and counsel patients to maintain a consistent 90-minute bedtime window across all days, including weekends, as part of cardiovascular risk reduction.
31. Huberman Lab
How to Overcome Social Anxiety | Dr. Nick Epley
Published: 2026-05-18
URL: Listen Here
Summary
Evidence converges that small, authentic social exchanges meaningfully improve mental and physical well-being. Social anxiety is best treated with real-world exposure that recalibrates overly pessimistic beliefs about others. Voice and in-person modalities humanize and increase perceived intelligence relative to text, suggesting clinicians and clients should favor voice/in-person touchpoints when feasible.
Key Takeaways
Real-world social exposure—not simulation—reduces social anxiety by updating inaccurate predictions about rejection; people are helped and accepted more often than they expect.
Brief, everyday interactions (greetings, small talk, sincere compliments) reliably lift mood; the biggest well-being gain comes from moving from no contact to some contact.
Voice conveys rich mental-state cues that humanize others; compared with text, speaking increases perceived intelligence and mutual understanding, especially across divides.
We routinely misread others due to cognitive biases (egocentrism, stereotyping, correspondence bias); testing assumptions through low-stakes bids to connect corrects many misinferences.
Short periods of acting more extraverted increase positive affect for most people, including introverts; small, repeated real interactions function as effective ‘social prescriptions’.
Clinical Insight
Loneliness and social isolation are modifiable risk factors linked to increased all-cause mortality, cardiometabolic burden, and dysregulated stress physiology. For social anxiety, graded in vivo exposure is an evidence-based intervention that changes maladaptive social predictions (e.g., overestimating rejection) rather than merely dampening arousal.
Actionable Takeaway
Implement a 2-week graded social exposure plan: daily, initiate one brief, real interaction (e.g., greet a neighbor or cashier, ask a small favor, offer a sincere compliment); log predicted outcome vs. actual outcome to capture expectancy violations. Each week, add 2–3 short voice calls (not texts) to trusted contacts. Progressively increase depth or duration as mispredictions correct.
32. Huberman Lab
How to Overcome Social Anxiety | Dr. Nick Epley
Published: 2026-05-18
URL: Listen Here
Summary
Dr. Nick Epley discusses how everyday social connections—especially those using richer cues like voice and eye contact—improve mental and physical health, and how misbeliefs about others’ interest create avoidant behavior and social anxiety. He outlines evidence that real-world exposure updates these misbeliefs, highlights the health costs of isolation, and offers practical ways to cultivate frequent, small interactions that enhance well-being.
Key Takeaways
Real-world exposure (not simulation) is the most effective way to reduce social anxiety because it updates mistaken beliefs about rejection and others’ responses.
People reliably underestimate how much others want to engage and help; silence and phone use are often misread as disinterest, leading to missed opportunities for connection.
Richer communication channels—especially voice (and eyes/visual behavior when available)—convey the ‘presence of mind,’ reduce dehumanization, and improve mutual understanding compared with text-only exchanges.
Small, daily social interactions (brief greetings, compliments, short conversations) measurably improve mood and health; moving from no contact to some contact yields the biggest well-being gains.
Acting more extroverted (within one’s comfort) increases positive affect across the introversion–extroversion spectrum; building simple, repeatable social habits is key.
Clinical Insight
For patients with social anxiety, the core therapeutic lever is belief change achieved through graded, in vivo exposure to real social interactions—patients learn (through experience) that positive or neutral responses are far more common than anticipated, which reduces avoidance and improves functioning.
Actionable Takeaway
Prescribe a graded real-world exposure plan: ask the patient to complete one brief, low-stakes social action daily (e.g., greet a stranger, ask for minor help, offer a sincere compliment), log the outcome, and review weekly to challenge overestimated rejection fears and reinforce corrective learning.
33. The Human Upgrade: Biohacking for Longevity & Performance
The Biblical Anti-Aging Fruit That Scientists Are Obsessed With : 1470
Published: 2026-05-21
URL: Listen Here
Summary
This episode details the discovery-to-clinic journey of urolithin A (Mitopure) as a nutritional mitophagy activator that enhances mitochondrial function, with human data showing improved immune cell composition and mitochondrial gene expression after 4 weeks and topical studies demonstrating better collagen signaling and wrinkle reduction. It provides dosing guidance and highlights the limitations of pomegranate-derived precursors, underscoring UA’s relevance for clinicians integrating mitochondrial-targeted interventions into healthy aging care.
Key Takeaways
Urolithin A (Mitopure), a gut-derived postbiotic from pomegranate ellagitannins, activates mitophagy and improves mitochondrial function; preclinical work showed ~45% lifespan extension in C. elegans and ~40% endurance gains in aged mice.
In a human study (Nature Aging), adults aged 50–70 taking 1 g/day for 4 weeks had increased naïve CD8 T cells and NK cells, decreased inflammation, and upregulated mitochondrial gene expression/function in immune cells.
Muscle biopsy studies show increased expression of mitochondrial genes after 4 weeks of oral urolithin A at 500–1,000 mg/day, helping define an effective daily dose (≥500 mg) for clinical use.
Topical urolithin A improved skin biology and appearance: increased collagen-related gene expression, >10% reduction in UV-induced inflammation, and statistically significant wrinkle reduction by 8 weeks (signals as early as 2 weeks).
Only ~30–40% of people can convert pomegranate polyphenols into urolithin A; direct UA supplementation provides reliable exposure versus juice/extracts (which also add sugar/oxalates).
Clinical Insight
Urolithin A is an evidence-based mitophagy activator with early clinical signals in muscle and immune aging; consistent supplementation (≥500 mg/day) can improve mitochondrial-related biomarkers and immune cell profiles in midlife and older adults, offering a practical adjunct for healthy aging strategies.
Actionable Takeaway
For eligible adults focused on longevity or mitochondrial health, consider urolithin A 500 mg daily (up to 1,000 mg) taken consistently for 2–4 months before assessing response; avoid relying on pomegranate extracts due to variable microbiome conversion, and optionally pair with topical UA for skin benefits.
34. The Human Upgrade: Biohacking for Longevity & Performance
The Biblical Anti-Aging Fruit That Scientists Are Obsessed With : 1470
Published: 2026-05-21
URL: Listen Here
Summary
This episode details the discovery-to-clinic journey of urolithin A as a mitophagy activator that targets a root mechanism of aging: mitochondrial dysfunction. The discussion reviews preclinical and human data showing improvements in muscle mitochondrial gene expression, immune cell composition, and topical skin outcomes, positioning urolithin A as a practical, evidence-supported addition to longevity care. (Note: Some study specifics were summarized at a high level in the transcript and may lack full methodological details.)
Key Takeaways
Urolithin A (commercialized as Mitopure/Timeline) is a postbiotic derived from pomegranate ellagitannins via gut microbes; only ~30–40% of people naturally convert, so a standardized supplement ensures reliable delivery at effective doses.
Mechanism of action is mitophagy activation (selective recycling of dysfunctional mitochondria), with preclinical data showing ~45% lifespan extension in C. elegans and ~40% greater running endurance in aged mice.
Human data: 4 weeks of 500 mg–1 g/day increased mitochondrial gene expression in skeletal muscle biopsies; clinical benefits are most apparent with consistent daily use over 2–4 months.
Immune health (Nature Aging study): adults aged 50–70 taking 1 g/day for 1 month had increased naive CD8 T cells and NK cells and reduced inflammatory signaling.
Topical urolithin A increased collagen-related gene expression, reduced post-UV skin inflammation (~10%), and produced statistically significant reductions in fine lines/wrinkles by 8 weeks; L’Oréal is collaborating to incorporate the ingredient based on shared research.
Clinical Insight
Standardized urolithin A is a clinically investigated mitophagy activator that can improve mitochondrial biomarkers and favorably shift immune cell populations in older adults within weeks, supporting its use as a safe, adjunctive tool to enhance healthspan beyond traditional approaches (e.g., NAD precursors, rapamycin).
Actionable Takeaway
For adults over ~50, consider a monitored 8–12 week trial of urolithin A at 500–1000 mg orally once daily; track patient-reported energy/exercise tolerance and optionally inflammation markers (e.g., CRP) or simple functional tests, and avoid substituting pomegranate extract due to variable microbiome conversion.
35. Huberman Lab
Build Muscle, Great Posture & Resilience to Injury | Jeff Cavaliere
Published: 2026-05-25
URL: Listen Here
Summary
This episode emphasizes that “small” accessory work—especially for the glute medius, rotator cuff, neck, grip, and feet—makes the big lifts possible for decades by preventing pain and improving function. Cavaliere outlines practical screens (e.g., old‑man shoe/sock test) and brief, low‑equipment drills that clinicians and trainees can integrate alongside flexible programming and sensible nutrition to support long‑term health, performance, and injury resilience.
Key Takeaways
Small, often-neglected muscles and motor control (glute medius, rotator cuff, neck flexors/extensors, foot intrinsics) are foundational for pain-free longevity and enable progress on the big compound lifts.
A large share of nonsurgical low back pain reflects gluteal weakness and pelvic control deficits (e.g., Trendelenburg pattern) rather than spine pathology; targeted work (reverse hypers, wall ‘hip hike,’ banded hip rotation) can resolve symptoms and prevent recurrence.
Medial elbow pain during pulling is frequently a grip/hand position issue (overloading ring/pinky at the fingertips); using a knuckles-over-bar grip and loading the meat of the hand often eliminates symptoms.
Shoulder durability depends on external rotator strength and posture—train banded external rotation with the elbow pinned (towel cue), use face pulls, and avoid chronically elevated, internally rotated positions.
Programming principles: take safer/isolation movements to (or near) failure, avoid true failure on complex lifts, count indirect volume (e.g., biceps on back day), and use flexible scheduling (even ‘split the split’) rather than forcing a 7‑day template; pair with simple daily/weekly function tests (old‑man shoe/sock test, side‑plank with top-leg abduction) and sensible ‘clean omnivore’ nutrition.
Clinical Insight
For many patients with common musculoskeletal complaints (e.g., nonspecific low back pain, shoulder impingement symptoms, medial elbow pain), the primary driver is often weakness or poor motor control in adjacent or distal links of the kinetic chain (glute medius/pelvic control, rotator cuff external rotators, grip mechanics) rather than structural pathology—prioritizing targeted strengthening and technique cues can reduce pain, restore function, and decrease unnecessary imaging or surgical referrals.
Actionable Takeaway
For chronic, nonspecific low back pain, screen glute medius function (single‑leg stance/Trendelenburg sign) and prescribe a 5–7 minute, 3x/week accessory routine: wall ‘hip hike’/abduction (2–3 sets/side) plus reverse hypers or prone hip extension with a brief hold at peak contraction (2–3 sets). Reassess gait and pain after 2–4 weeks and progress to banded hip ER/IR as tolerated.
36. Huberman Lab
Essentials: The Science & Process of Healing from Grief
Published: 2026-05-28
URL: Listen Here
Summary
This episode reframes grief as a neurobiological remapping process across space, time, and closeness, emphasizing that yearning arises from motivation circuits rather than depression per se. It offers practical, physiology-informed tools—structured grieving sessions, vagal tone enhancement, and sleep/cortisol stabilization—to support adaptive progression through grief and reduce risk of complicated grief. Some imaging findings and animal-to-human links were discussed without full study citations in the episode.
Key Takeaways
The brain maps relationships across three braided dimensions—space, time, and closeness—and grief is the neuroplastic remapping that uncouples space/time predictions from an intact sense of attachment.
fMRI work highlights the inferior parietal lobule as a common code for physical distance, temporal spacing, and social closeness, while motivation/“yearning” circuits (e.g., nucleus accumbens) are prominently engaged in grief.
Individual differences in oxytocin signaling—particularly receptor density within reward/motivation circuits—help explain variability in the intensity and persistence of yearning during grief.
The Kübler-Ross stages are not universal; grief and depression share symptoms but are distinct processes with different neurobiological underpinnings.
Structured “rational grieving” (time-limited sessions that fully feel attachment while avoiding counterfactual thinking), supported by physiologic tools (enhancing vagal tone, stabilizing diurnal cortisol via morning light, prioritizing sleep/NSDR), promotes adaptive grieving and may reduce risk for complicated grief.
Clinical Insight
Effective grieving preserves the felt attachment while deliberately remapping space and time predictions; interventions that enhance vagal tone and normalize diurnal cortisol can facilitate this adaptive neuroplastic transition and help prevent complicated grief.
Actionable Takeaway
Schedule a daily 10–20 minute “rational grieving” session: intentionally feel your attachment to the deceased while actively avoiding counterfactual (“what if”) thoughts; before starting, perform 2–3 minutes of slow, exhale-emphasized breathing to increase vagal tone and stability during the session.
37. Huberman Lab
Peptides: The Science, Uses & Safety | Dr. Abud Bakri
Published: 2026-06-01
URL: Listen Here
Summary
The discussion frames peptides by receptor biology and evidence strength. Trial-backed metabolic peptides (GLP-1/GIP) contrast with research-stage compounds (e.g., BPC-157, thymic/epigenetic peptides) that lack rigorous human data. Emphasis is on clinical guardrails: verified sourcing, slow titration where applicable, and objective monitoring for efficacy and safety.
Key Takeaways
Prioritize peptides with defined receptors and robust human data (e.g., GLP-1 agonists); treat others with limited evidence (e.g., BPC-157, TB-4/Thymosin-β4, epithalon) as experimental.
BPC-157 shows promising animal data for GI and tissue repair but lacks high-quality human trials; safety, sourcing, and regulatory status are major concerns.
GLP-1/GIP agents (e.g., semaglutide, tirzepatide) deliver substantial, trial-proven weight and metabolic benefits when titrated slowly and paired with lifestyle support.
Thymic peptides and GH secretagogues may influence immune/body composition markers but require careful monitoring (e.g., IGF-1, glucose/insulin sensitivity) and medical oversight.
Quality control and legality matter: avoid gray-market products; verify compounding/pharmacy sources and monitor objective biomarkers.
Clinical Insight
Think pharmacology-first: confirm target, mechanism, human outcomes, and safety monitoring before considering any peptide, and avoid non-verified supply chains.
Actionable Takeaway
If using a GLP-1 agonist for weight management, start at the lowest dose, titrate every ~4 weeks as tolerated, maintain nutrition/resistance training, and monitor GI tolerance, hydration, and mood—under clinician supervision with pharmacy-verified products.
38. The Human Upgrade: Biohacking for Longevity & Performance
Putin Longevity, Pancreatic Cancer Cure, AI Therapy, GLP-1 Breast Cancer... : 1479
Published: 2026-06-05
URL: Listen Here
Summary
This episode reviews emerging fronts in cancer and longevity—from oncolytic viruses in pancreatic cancer and the potential cancer‑risk impact of GLP‑1 RAs, to the superior long‑term evidence for sauna versus cold exposure—while cautioning against adolescents’ reliance on AI chatbots for mental health. It also flags Russia’s large‑scale state investment in longevity technologies and its implications for global science. Limitations: several findings are preliminary or observational, and some sources were not formally cited in the episode.
Key Takeaways
An early safety study injecting an engineered oncolytic virus directly into pancreatic tumors (n=3) showed intratumoral replication, tumor cell lysis, and apparent immune activation even at low dose—suggesting feasibility in a treatment‑resistant cancer.
Survey data indicate ~19% of adolescents and young adults turn to AI chatbots when distressed (highest in ages 18–21), raising concern about dependency and delayed access to human mental health care.
A Penn Medicine retrospective cohort (>111,000 women, ages 45–80, BMI ≥25) found GLP‑1 receptor agonist exposure associated with ~30–35% lower odds of breast cancer; while observational, authors call for randomized trials and mechanisms may include improved insulin resistance and reduced inflammation.
Sauna use has robust long‑term human data linking higher frequency (≥4 sessions/week) to lower cardiovascular and all‑cause mortality; by contrast, cold exposure shows acute benefits with limited long‑term human outcomes despite mechanistic interest (e.g., RBM3).
The Wall Street Journal reports Russia’s ~$26B state longevity program (gene therapy, bioprinting, xenotransplantation) led by Maria Vorontsova and Mikhail Kovalchuk, highlighting potential scientific advances and concerns about data openness.
Clinical Insight
Addressing metabolic dysfunction (insulin resistance, chronic inflammation) may meaningfully reduce cancer risk—illustrated by observational data linking GLP‑1 RA use to lower breast cancer incidence—supporting integration of metabolic optimization into preventive and oncologic care while awaiting randomized trials.
Actionable Takeaway
When appropriate, counsel patients to incorporate regular sauna bathing as a longevity and cardiovascular risk‑reduction modality (e.g., ~4 sessions/week, 15–20 minutes at typical Finnish sauna temperatures), after screening for contraindications such as unstable cardiovascular disease, hypotension, dehydration, pregnancy, or heat intolerance.
39. The Human Upgrade: Biohacking for Longevity & Performance
Putin Longevity, Pancreatic Cancer Cure, AI Therapy, GLP-1 Breast Cancer... : 1479
Published: 2026-06-05
URL: Listen Here
Summary
This episode reviews emerging signals in oncology and longevity: early oncolytic virus results in pancreatic cancer, observational evidence linking GLP-1 use to lower breast cancer odds, and the strategic expansion of state-level longevity R&D in Russia. It also contrasts robust longitudinal data favoring frequent sauna use for longevity with the more limited human evidence base for cold exposure, and highlights risks of adolescents relying on AI chatbots for mental health support.
Key Takeaways
Early safety-dose intratumoral oncolytic virus therapy in pancreatic cancer reportedly induced tumor cell lysis and immune activation in three patients, suggesting a promising mechanism in a notoriously resistant malignancy.
Roughly 19% of adolescents and young adults report using AI chatbots for emotional support; while perceived as helpful, this may foster dependence and delay access to human-delivered mental health care.
A Penn Medicine retrospective cohort of ~111,000 women (ages 45–80; BMI ≥25) found GLP-1 receptor agonist exposure associated with ~30–35% lower odds of breast cancer versus non-users; causality is unproven and trials are needed.
Russia is reportedly launching a $26B state-backed anti-aging initiative (gene therapy, organ bioprinting, xenotransplantation), signaling accelerating investment in longevity science but raising concerns about data openness.
Long-term Finnish data link frequent sauna use (≥4 sessions/week) to lower cardiovascular and all-cause mortality; cold exposure offers acute benefits but lacks comparable long-term human outcomes data for longevity.
Clinical Insight
Optimizing metabolic health remains central to preventive oncology: observational data suggest GLP-1 receptor agonists may reduce breast cancer risk alongside benefits in weight, insulin resistance, and inflammation, but clinicians should interpret this as hypothesis-generating until randomized trials confirm causality.
Actionable Takeaway
For patients without contraindications, recommend regular sauna use as a primary longevity modality (target ≥4 sessions/week as tolerated) to support cardiovascular risk reduction and overall mortality benefits, with counseling on hydration, blood pressure monitoring, and heat safety.
40. The Human Upgrade: Biohacking for Longevity & Performance
Putin Longevity, Pancreatic Cancer Cure, AI Therapy, GLP-1 Breast Cancer... : 1479
Published: 2026-06-05
URL: Listen Here
Summary
This episode spotlights emerging and established interventions across oncology, mental health, and longevity: early oncolytic virotherapy signals in pancreatic cancer, observational data linking GLP-1 use to lower breast cancer incidence, and strong evidence favoring regular sauna for mortality risk reduction over cold plunges for longevity. It also flags rising youth reliance on AI chatbots for emotional support and Russia’s state-scale investment in anti-aging technologies, underscoring opportunities and cautions for clinicians navigating fast-moving health innovations.
Key Takeaways
A first-in-human safety study injecting an engineered oncolytic virus directly into pancreatic tumors (n=3) showed intratumoral replication, tumor cell lysis, and an immune response even at low dose—an encouraging signal in a notoriously treatment-resistant cancer.
About 19% of adolescents and young adults report turning to AI chatbots for emotional support, with highest use in ages 18–21; hosts caution that chatbot engagement may foster dependency and delay access to real clinical care.
A large Penn Medicine retrospective cohort (~111,000 women, ages 45–80, BMI ≥25) found GLP-1 receptor agonist exposure associated with ~30–35% lower odds of breast cancer versus non-use; observational design precludes causality but aligns with metabolic risk-reduction mechanisms.
Russia reportedly launched a ~$26B state-backed longevity initiative (gene therapy, xenotransplantation, organ bioprinting), signaling sovereign-scale investment in anti-aging science but raising concerns about openness and data sharing.
Sauna use has robust long-term human data linking higher frequency (≥4 sessions/week) to reductions in cardiovascular and all-cause mortality, whereas cold plunges show mainly acute benefits (alertness, soreness, mood) with limited human longevity outcomes to date.
Clinical Insight
Improving metabolic health may meaningfully influence cancer risk: a large observational analysis suggests GLP-1 receptor agonist use in overweight/obese midlife-to-older women correlates with substantially lower breast cancer incidence, reinforcing metabolic dysfunction as an actionable cancer risk pathway and warranting randomized trials.
Actionable Takeaway
For appropriate patients without contraindications, recommend regular sauna bathing as a primary longevity modality—aim for four or more sessions per week—while using cold exposure chiefly for acute performance/recovery rather than long-term longevity benefits.
41. The Human Upgrade: Biohacking for Longevity & Performance
The Foods That Starve Cancer | William Li : 1481
Published: 2026-06-09
URL: Listen Here
Summary
Dr. William Li discusses how diet can influence cancer via angiogenesis, framing vascular growth as a balanced, homeostatic system while advocating for personalized, longitudinal biomarker tracking to extend healthspan. He also highlights emerging evidence that inhaled and ingested microplastics embed in atherosclerotic plaques and brain tissue, correlate with inflammation, and predict substantially higher cardiovascular event rates—making exposure reduction and vascular monitoring immediate priorities.
Key Takeaways
In rigorous angiogenesis assays, about half of tested whole-food extracts equaled or outperformed anti-angiogenic cancer drugs, supporting a biologically plausible role for diet in modulating tumor blood supply.
Angiogenesis is a homeostatic system: endogenous growth factors and inhibitors act like a dial, so the clinical goal is physiologic balance (not blanket inhibition) to support vascular health, muscle growth, tissue repair—and to avoid feeding tumors.
Longevity insights from centenarians/super‑centenarians point to stronger immunity, lower inflammation, healthier metabolism, gut, and vasculature; genetics and lifestyle each contribute substantially (~50/50), with stress resilience (e.g., vagus‑nerve engagement, HRV) as a key modifiable factor.
Vascular resilience is measurable and trainable; tracking pulse wave velocity (PWV), HRV, VO2 max, temperature shifts, and (where available) flow‑mediated dilation (FMD) can guide personalized prevention and course‑corrections over time.
Microplastics are an emerging cardiovascular and neuro risk: major exposure is via inhalation (e.g., tire‑wear particles) and ingestion (packaging, some gums); particles have been found in carotid plaques and brain tissue and are associated with higher inflammatory markers and ~4× higher 3‑year risk of MI/stroke/death.
Clinical Insight
Environmental microplastic burden has clinically meaningful cardiovascular implications—plaque-embedded microplastics correlate with systemic inflammation and markedly higher major adverse cardiovascular events—so clinicians should pair exposure‑reduction counseling with aggressive vascular risk management and longitudinal vascular function monitoring.
Actionable Takeaway
Incorporate pulse wave velocity (PWV) into routine risk assessment and trend it over time; if elevated, intensify LDL and blood‑pressure targets and aerobic training, and counsel on microplastic reduction (use HEPA air filtration and high‑grade cabin filters, minimize plastic‑packaged ultra‑processed foods, and avoid plastic‑containing chewing gum).
42. The Human Upgrade: Biohacking for Longevity & Performance
The Foods That Starve Cancer | William Li : 1481
Published: 2026-06-09
URL: Listen Here
Summary
Dr. William Li discusses how vascular health and angiogenesis balance underpin longevity, with evidence that dietary bioactives can influence cancer‑relevant pathways and that centenarian biology clusters around low inflammation, robust immunity, and healthier vasculature. He highlights practical measurement tools (FMD, PWV), the emerging cardiovascular risk signal from microplastics, and stress‑resilience strategies (vagal activation/HRV) as levers clinicians can apply now. Note: despite the episode title, specific food lists to ‘starve cancer’ were not detailed in this transcript segment.
Key Takeaways
Food bioactives can modulate angiogenesis: in blinded in‑vitro testing, several food extracts matched or exceeded anti‑angiogenic cancer drugs in potency, supporting diet’s role in cancer defense and vascular health.
Angiogenesis is a homeostatic system; endogenous growth factors and inhibitors dynamically balance vessel growth—clinical goals should emphasize vascular balance and resilience, not chronic inhibition.
Centenarian research (including super‑agers) shows consistent signatures—stronger immunity, lower inflammation, healthier metabolism, gut, and vascular function—with longevity shaped by both genetics and lifestyle/exposures.
Vascular resilience is measurable: flow‑mediated dilation (FMD) and pulse wave velocity (PWV) are practical markers that can be trended over time; better, accessible hardware paired with software is a key need.
Microplastics are pervasive (notably from tire wear) and enter via gut, lungs, and olfactory pathways; their presence in carotid plaques correlates with higher inflammatory markers and ~4‑fold greater 3‑year risk of MI/stroke/death.
Clinical Insight
Microplastics embedded in carotid atheroma are associated with elevated inflammatory biomarkers and a markedly increased risk of major cardiovascular events, underscoring the importance of proactive vascular assessment and practical exposure‑reduction counseling in clinical practice.
Actionable Takeaway
Incorporate arterial stiffness/resilience tracking into midlife risk assessment—measure pulse wave velocity in clinic (or with a validated consumer device) annually and add flow‑mediated dilation where available; use trends to tailor interventions (exercise, diet quality, BP/lipid control) and recheck more frequently in high‑risk patients.
43. Health Longevity Secrets
What If The Pain Is Actually The Fuel? — Ben Barbic
Published: 2026-06-16
URL: Listen Here
Summary
This episode profiles musician-author Ben Barbic’s transformation from unhealthy habits and hypertension to a resilient, purpose-driven life built on micro-habits and creative anchors. It highlights how reframing pain as fuel and layering small, consistent behaviors—meditation, movement, learning—can produce durable change, offering a practical model clinicians can adapt in behavior-change counseling.
Key Takeaways
A single pivot moment—rooted in purpose and fatherhood—led Ben Barbic at age 28 to remove alcohol, nicotine, and poor diet, initiating lasting change.
He built a 15-year resilience ‘operating system’ anchored in small daily habits: music/creativity, meditation (kirtan + chakra practices), movement (running/weights), education/reading, and supportive community.
Start by removing key vices, then add positive anchors; micro-steps compound over time and are more sustainable than sweeping overhauls.
Reframe adversity as fuel: the redwood-tree metaphor illustrates embracing scars and turning low points into launchpads for growth.
Continuous learning and contribution/legacy reframed success—from “catching up” to sharing tools and insights that help others.
Clinical Insight
Eliciting a patient’s core purpose and leveraging micro-habit formation—beginning with removal of salient harms (alcohol, nicotine, ultra-processed foods) and adding simple anchors like brief daily meditation and movement—can catalyze durable lifestyle change that supports cardiometabolic risk reduction and mental well-being.
Actionable Takeaway
With a patient struggling with hypertension/unhealthy coping, co-create a 2‑week micro-plan: remove one high-impact vice (e.g., nightly alcohol) and add a 10‑minute daily guided meditation plus two 20‑minute walks per week; schedule a follow-up to reinforce wins and add the next small habit.
44. The Human Upgrade: Biohacking for Longevity & Performance
The Skin Mistakes That Age You Fast and Kill You Slow | Dr. Michael Christopher : 1485
Published: 2026-06-16
URL: Listen Here
Summary
This episode emphasizes that rigorous dermoscopy by trained clinicians dramatically improves early melanoma detection, which is pivotal for survival. It also provides pragmatic guidance on sun exposure (dose‑based protection), topical tretinoin for skin health, and cautions regarding AI apps and melanotan use—framing practical steps physicians can apply now.
Key Takeaways
Systematic dermoscopy—placing a dermatoscope on every lesion during full‑body skin exams—can markedly increase melanoma detection; many clinicians underuse the tool or lack proficiency.
Early detection is critical: stage I melanoma has ~99% survival versus ~73–74% at stage III (NCCN); melanoma is the most lethal common skin cancer, and squamous cell carcinoma also causes substantial mortality due to high incidence.
Manage sun by dose, not dogma: never burn, use the UV index to guide exposure, favor mineral sunscreens (zinc oxide/titanium dioxide), and protective clothing; visible light can still darken skin even with sunscreen.
Topical tretinoin (Retin‑A) nightly is a high‑value, evidence‑based cornerstone for photoaging and actinic keratoses; expect initial irritation, wash off in the morning, and avoid during pregnancy/breastfeeding.
Consumer AI skin-cancer apps are not yet reliable for diagnosis; peptides like melanotan may darken nevi and carry theoretical risks—use caution, particularly in patients with high melanoma risk.
Clinical Insight
Adopting a standardized, full‑body dermatoscopic examination with clinician training in dermoscopic pattern recognition is likely the highest‑impact change to improve early melanoma detection and outcomes.
Actionable Takeaway
Implement a clinic protocol to dermatoscope every lesion during full‑body skin checks (clear surface artifacts with alcohol, document concerning structures, biopsy/monitor as indicated), and counsel patients on UV‑index–guided sun behavior (no sunburns, mineral sunscreens, protective clothing).
45. Microbiome Medics
Eat to Sleep: The Power of Chrononutrition and Circadian Rhythms
Published: 2026-06-17
URL: Listen Here
Summary
This episode synthesizes how circadian biology, sleep architecture, diet timing/quality, and the gut microbiome interact to shape mood, metabolic health, and therapeutic response. The hosts outline practical strategies—CBT-I, morning light, regular sleep/wake times, chrononutrition, fiber and fermented foods, and selective probiotics—to restore circadian alignment and improve sleep-dependent mental and physical outcomes, with special consideration for shift workers.
Key Takeaways
Circadian rhythms orchestrate nearly all physiology (hormones, metabolism, digestion, cognition), and disruption from shift work, jet lag, or “social jet lag” (weekend sleep-ins >1 hour) impairs sleep, mood, and metabolic health.
Sleep has distinct architecture: early-night deep NREM sleep supports repair (e.g., growth hormone, ADH) while late-night REM sleep supports emotional processing and problem-solving; even one poor night skews appetite toward ultra-processed foods, reduces activity, and worsens mood.
The gut microbiome both influences and is influenced by circadian rhythms; disruption reduces beneficial taxa (e.g., Lactobacillus, Bifidobacterium), short-chain fatty acids, and barrier integrity, increasing inflammatory microbes and permeability, with downstream brain effects via the gut–brain axis.
Chrononutrition matters: consistent meal timing and avoiding late-night eating help realign peripheral clocks and microbial diurnal rhythms; higher-fiber, minimally processed dietary patterns relate to better sleep and mental health, whereas caffeine (late in day) and alcohol fragment sleep architecture.
Evidence-informed interventions include CBT-I (including digital CBT-I), morning light exposure, consistent sleep/wake schedules, higher-fiber and fermented foods (moderation), and—in select cases—probiotics (Lactobacillus, Bifidobacterium, Saccharomyces) to improve sleep quality and daytime sleepiness.
Clinical Insight
In patients with mood symptoms, prioritize assessment and treatment of sleep and circadian alignment—including regular meal timing and microbiome-supportive nutrition—because improving sleep causally improves mental health and metabolic outcomes.
Actionable Takeaway
Advise patients to adopt a consistent 10–12-hour daytime eating window that ends at least 3 hours before bedtime (no late-night eating) to realign circadian rhythms and support the gut microbiome; reassess sleep and daytime function after 2–4 weeks.
46. Huberman Lab
The Mental Frame & Specific Daily Actions to Succeed | Andy Stumpf
Published: 2026-06-15
URL: Listen Here
Summary
This episode centers on practical frameworks for agency, discipline, and mental health: a weekly ‘Concern vs Influence’ tool to shift attention to controllables, strategies to curb social media’s addictive pull, and the value of small, consistent hard choices to build resilience. It also addresses nuanced aspects of suicide risk in elite veterans—including isolation, alcohol use, and pre‑existing trauma—and highlights the importance of early, direct check‑ins and accessible support. Note: summary is based on the provided (partial) transcript; some details of the full episode may not be captured.
Key Takeaways
A simple weekly ‘Concern vs Influence’ exercise (two-column list) powerfully refocuses attention onto controllable behaviors, increases perceived agency, and reduces rumination.
Social media can function as a ‘low‑resolution’ addiction; intentionally capping screen time (e.g., <60–90 minutes/day) and shifting use to a laptop markedly improved subjective mental health for the guests.
Cold exposure is an effective arousal and resilience tool but should not be done immediately after resistance training because it can blunt strength/hypertrophy adaptations; heat–cold use should be applied thoughtfully and safely.
Consistently choosing the slightly harder option in small daily tasks (e.g., dishes, replacing toilet paper, organizing) builds micro‑discipline and generalizes to greater resilience; doing things you don’t want to do strengthens perseverance circuits.
Suicide risk in high-performing veterans can involve isolation, alcohol use, and a painful gap between self‑standards and current functioning; pre‑service trauma often co‑exists. Direct, frequent check‑ins and accessible support pathways matter—do not assume people will ask for help.
Clinical Insight
For physicians, high-functioning patients (including veterans) may harbor significant, concealed risk: screen for isolation, alcohol use, social media overuse, and pre‑service trauma, and offer simple cognitive-behavioral tools like the weekly ‘Concern vs Influence’ exercise to restore agency. Small, consistent acts of effort and doing the “unwanted but healthy” behavior can strengthen perseverance (anterior mid‑cingulate cortex function) and improve coping across domains.
Actionable Takeaway
Prescribe a 10-minute, once‑weekly ‘Concern vs Influence’ journaling exercise: draw a line down a page, list all current stressors under ‘Concern’ (left) and only what is directly controllable under ‘Influence’ (right—self, time management, next steps). Ask patients to choose 1–2 right‑column actions to do within 24 hours and repeat weekly for one month.
47. Docs Who Lift
Are Peptides the New Snake Oil? What the Actual Science Says With Barbell Medicine
Published: 2026-06-17
URL: Listen Here
Summary
The discussion clarifies what peptides are, why many popular ‘research’ peptides lack credible human evidence, and why RCTs are essential for determining benefit and harm. It contrasts unsupported products with FDA-approved peptide drugs (e.g., GLP-1s, tesamorelin, bremelanotide), underscores safety/quality issues in research-chemical markets, and urges clinicians to uphold consistent evidence standards when counseling patients.
Key Takeaways
Most online-marketed peptides are drugs, not supplements; without robust human data, therapeutic claims are unreliable, and many peptides are not orally bioavailable.
Popularity is driven by GLP-1 success/shortages, compounding/research-chemical markets, normalization of self-injection, and social media promotion.
Human evidence for many trendy peptides (e.g., BPC-157, TB-500, AOD-9604, MOTS-c) is weak or absent, while a few peptide drugs (e.g., GLP-1s, tesamorelin, bremelanotide) are FDA-approved with strong data.
Anecdotes and mechanistic plausibility cannot replace randomized, controlled human trials for establishing safety, dosing, and efficacy.
Quality and safety risks are significant in gray markets (mislabeled/adulterated products; case reports of harm), favoring regulated, evidence-based therapies.
Clinical Insight
Apply the same evidentiary bar to peptides as to any drug: without high-quality human data and reliable manufacturing, do not recommend or prescribe, and redirect patients to approved peptide therapeutics when appropriate.
Actionable Takeaway
When asked about a peptide, quickly check ClinicalTrials.gov and peer-reviewed literature; if no credible human RCTs or quality assurances exist, advise against use, discuss risks, offer approved alternatives aligned with the patient’s goal (e.g., GLP-1 RA for weight/metabolic aims, tesamorelin for HIV-associated visceral adiposity, bremelanotide for HSDD), and document counseling.
48. Huberman Lab
Essentials: Improve Flexibility with Research-Supported Stretching Protocols
Published: 2026-06-18
URL: Listen Here
Summary
This episode distills the neuroscience of flexibility and provides research-supported protocols favoring low-intensity static stretching to achieve durable ROM gains. Practical guidance emphasizes weekly volume (≥5 minutes/muscle), short daily sessions, proper warm-up, and timing after exercise, with recognition of central adaptations (insula) that enhance pain tolerance and relaxation.
Key Takeaways
Flexibility is governed by neural, muscular, and connective-tissue components; muscle spindles and Golgi tendon organs regulate stretch and load, while higher centers (insula, von Economo neurons) can modulate tone and pain to permit greater range of motion (ROM).
For lasting ROM gains, static stretching (including PNF variants) with ~30-second holds is most effective; accumulating at least 5 minutes per week per muscle group and practicing on ~5 or more days per week yields significant improvements.
Low-intensity static stretching (about 30–40% of the pain/discomfort threshold; “microstretching”) improves active ROM more than moderate-intensity (~80%) efforts and likely reduces injury risk.
Warm up before stretching and place static stretching after training or after a brief (5–10 min) cardio/calisthenics warm-up; avoid pre-event static stretching when maximal strength or speed is desired, except when needed to achieve safe form.
Practices coupling stretching with interoceptive control (e.g., yoga) are associated with increased insular cortex gray matter and markedly higher pain tolerance, indicating central nervous system adaptations.
Clinical Insight
Low-intensity static stretching performed for 30–60 seconds per set, accumulated to at least 5 minutes per week for each target muscle group and scheduled post-exercise (or after a brief warm-up), produces superior and safer improvements in active range of motion than higher-intensity static stretching.
Actionable Takeaway
After workouts (or following a 5–10 minute light warm-up), prescribe 3 sets of 30–60-second low-intensity (≈30–40% of pain threshold) static holds for each target muscle group (e.g., hamstrings) on 5–7 days per week to reach ≥5 minutes/week total per muscle group; cue relaxed breathing and interoceptive focus, and avoid pre-performance static stretching unless needed for safe technique.
49. The Human Upgrade: Biohacking for Longevity & Performance
BDNF Superpowers Through MDMA and Ketamine | Dr. Dave Rabin : 1486
Published: 2026-06-18
URL: Listen Here
Summary
This episode explores how creating felt safety in the nervous system—via set, setting, skilled therapy, and somatic tools—enables psychedelics to drive neuroplastic and even epigenetic repair in trauma, with ketamine positioned as the safest, most accessible first‑line option. It emphasizes strict safety screening (especially avoiding serotonergic psychedelics with SSRIs/SNRIs), and highlights evidence that MDMA‑assisted therapy can reverse trauma‑linked cortisol receptor methylation in proportion to clinical gains. Note: analysis reflects the provided transcript excerpt, which includes advertisements and may not capture the full episode.
Key Takeaways
Ketamine is the most accessible and generally safest entry point for psychedelic-assisted therapy: it is legal in most U.S. states, short-acting (~60 minutes), and does not interact dangerously with SSRIs/SNRIs—unlike serotonergic psychedelics (e.g., psilocybin, LSD, MDMA) that can precipitate life‑threatening serotonin syndrome when combined with these medications.
Clinical outcomes with psychedelics hinge on safety (set, setting, and skilled therapy): the medicine facilitates bottom‑up learning and neuroplasticity (including BDNF‑mediated fear extinction via insula–amygdala pathways), but the therapeutic container and integration drive most of the benefit.
Trauma can be repaired down to epigenetic marks: MDMA‑assisted therapy for PTSD has been associated with reversal of trauma‑related methylation changes at cortisol receptor genes, with epigenetic repair proportional to symptom improvement.
Chronic stress and modern overstimulation bias the autonomic nervous system toward sympathetic arousal; simple somatic practices (e.g., paced breathing at ~5–7 breaths/min, mindfulness) rapidly activate the vagus nerve and shift physiology toward rest‑and‑digest, learning, and healing.
Conventional psychiatric drugs are effective for short‑term stabilization but often impede long‑term emotional learning by blunting interoception; labeling patients as “treatment‑resistant” often reflects mismatched treatment rather than patient failure.
Clinical Insight
For physicians, the pivotal determinant of psychedelic therapy efficacy is patient safety—physiologic and psychological—achieved through rigorous screening (including for bipolar/psychosis/personality disorders and serotonergic medications), structured preparation and integration, and a supportive therapeutic alliance; ketamine‑assisted psychotherapy is an evidence‑informed, legally accessible first‑line option that avoids SSRI/SNRI–related risks and can catalyze durable symptom and even epigenetic improvements.
Actionable Takeaway
Adopt a standardized intake and safety protocol for patients exploring psychedelic‑assisted care: (1) perform comprehensive medication reconciliation to identify SSRIs/SNRIs/MAOIs and avoid serotonergic psychedelics if present; (2) screen for bipolar, psychotic, delusional, and personality disorders; (3) when appropriate, offer ketamine‑assisted psychotherapy with defined preparation and integration sessions; and (4) prescribe daily vagal‑toning practices (e.g., 5–7 breaths/min paced breathing for 5–10 minutes) to enhance outcomes.
50. Huberman Lab
Essentials: Improve Flexibility with Research-Supported Stretching Protocols
Published: 2026-06-18
URL: Listen Here
Summary
This episode distills the neurophysiology of flexibility and presents research-backed protocols showing that brief, frequent, low-intensity static stretching after a warm-up best increases ROM. It also highlights central mechanisms (insula/von Economo neurons) and evidence from yoga research suggesting enhanced pain tolerance and autonomic regulation with consistent practice.
Key Takeaways
Flexibility is governed by neural, muscular, and connective-tissue mechanisms; muscle spindles and Golgi tendon organs set protective limits, while higher brain centers (insula, including von Economo neurons) can modulate reflexes and arousal to permit greater range of motion.
For lasting flexibility gains, static stretching (including PNF variants) is superior to dynamic/ballistic approaches; 30-second holds performed repeatedly yield the best improvements.
Total weekly stretching time per muscle group matters: accumulating at least 5 minutes per week (e.g., 3 × 30-second holds, 5 days/week) produces meaningful, durable range-of-motion (ROM) increases.
Low-intensity static stretching (≈30–40% of discomfort threshold, well below pain) improves active ROM more than moderate-intensity (~80%) stretching and likely reduces injury risk.
Stretch when warm—ideally after exercise or following 5–10 minutes of light activity; avoid pre-event static stretching when maximal strength, power, or speed are needed, unless correcting form limitations or during rehab.
Clinical Insight
Prescribing low-intensity static stretching—30-second relaxed holds performed for multiple sets, ≥5 days/week, after a warm-up—offers an effective, low-risk way to increase ROM and may confer central nervous system benefits (e.g., improved pain tolerance) relevant to rehabilitation and healthy aging.
Actionable Takeaway
For each target muscle group, after 5–10 minutes of light cardio or at the end of a workout, perform 3 sets of 30-second relaxed static holds at 30–40% of the pain threshold, 5 days per week (≥5 minutes total/week per muscle group); reserve pre-event static stretching only for cases where additional ROM is required to achieve safe technique.
51. This Week in Cardiology
Jun 19 2026 This Week in Cardiology
Published: 2026-06-19
URL: Listen Here
Summary
This episode synthesizes emerging 10-year data comparing TAVR and SAVR, highlighting higher reintervention and possible late mortality disadvantages for earlier-generation TAVR, mixed signals with newer devices, and the primacy of durability in younger, lower-risk patients. It also reviews a novel population-based estimate of valvular disease prevalence and critiques a CMS proposal to expand TAVR coverage to asymptomatic severe AS without mandating RCT-level evidence.
Key Takeaways
Permissive ICD programming (MADIT-RIT) substantially reduced inappropriate therapies (≈76–79%) and all-cause mortality (≈44–55%) versus conventional programming, likely contributing to observed declines in VT interventions among ICD patients.
In intermediate-risk severe AS (PARTNER 2A, Sapien XT), 10-year all-cause mortality was higher overall with TAVR versus SAVR (HR ~1.13), particularly with transapical access, and valve reintervention was markedly higher after TAVR (6.3% vs 1.6%).
A matched observational comparison of Sapien 3 TAVR versus SAVR showed similar 10-year mortality and reintervention, but important limitations (nonrandomized design, sponsor involvement, re-consent/missingness) temper conclusions; durability and modes of failure differ by platform.
Longer-term data in lower-risk cohorts (PARTNER 3, Evolut Low Risk, NOTION, UK TAVI) show neutral primary outcomes but signal numerically higher late death/disabling stroke and higher reintervention with TAVR, underscoring durability as a central consideration—especially in younger patients.
The PREVIEW Valve population study estimated an 8.2% prevalence of valvular disease in U.S. adults aged 65–85 (~4.7 million with ≥moderate disease) with lower AS/AI prevalence among Black individuals; CMS proposed expanding TAVR coverage to asymptomatic severe AS and permitting single-operator procedures, prompting calls for stronger evidence and maintenance of heart-team safeguards.
Clinical Insight
For patients with severe AS who are younger or have >10-year life expectancy, a SAVR-first strategy often better preserves lifetime management options (durability, coronary access, future valve sizing), while TAVR remains transformative for older/high-risk patients—emphasizing individualized, heart-team–guided, preference-sensitive decisions.
Actionable Takeaway
For low-surgical-risk severe AS patients <70–75 years, convene an unbiased multidisciplinary heart team visit that explicitly frames the choice as a lifetime valve strategy and, unless strong anatomic/comorbidity factors favor TAVR, recommend SAVR-first while documenting discussion of durability, coronary access, and future reintervention pathways.
52. The Human Upgrade: Biohacking for Longevity & Performance
Sugar-Free Backlash, Taurine Fail, Copper Brain Therapy, Childhood Biohacking, Strength Training : 1488
Published: 2026-06-19
URL: Listen Here
Summary
This episode spotlights how mechanistic thinking refines health decisions across domains: Alzheimer’s clearance pathways, microbiome impacts of dietary elimination, minimal effective resistance training for longevity, environmental determinants of child brain development, and taurine’s true role. It emphasizes practical, modifiable levers (sleep, exercise, environmental hygiene) over labels or marketing, while noting that some findings derive from animal and observational data without full citations.
Key Takeaways
A copper-based compound (CUATSM) in Alzheimer’s-model mice reduced amyloid-β by ~42%, improved spatial memory, and upregulated BBB P-glycoprotein (~24%), highlighting impaired clearance (not just overproduction) as a key Alzheimer’s mechanism and the nuance of copper homeostasis.
Eliminating sucrose from a low-fat diet in mice—without suitable replacements—led to insulin resistance, dysbiosis, intestinal inflammation, and fatty liver despite no weight gain, underscoring that abrupt dietary removal can harm the microbiome and that weight is a lagging indicator of metabolic health.
Observational data in ~147,000 adults over up to 30 years suggest 1–2 hours/week of resistance training—especially with aerobic exercise—is associated with the greatest reductions in cardiovascular and neurological mortality; consistency matters more than volume.
Socioeconomic conditions were the strongest predictors of structural brain differences on MRI in 9–10-year-olds, likely mediated by sleep deprivation, chronic stress, and screen exposure—modifiable environmental factors with biological consequences.
An acute 1 g dose of taurine before exercise did not improve VO2max or time to exhaustion; taurine’s benefits are more likely with chronic 3–6 g/day and relate to mitochondrial, cardiovascular, and neuro-modulatory roles (including blunting caffeine-induced jitter), not acute performance boosts.
Clinical Insight
For neurodegeneration, prioritize mechanisms that enhance brain waste clearance—sleep quality, metabolic and vascular control, and BBB transporter function (e.g., P-glycoprotein)—rather than focusing solely on amyloid suppression or simplistic mineral avoidance; copper homeostasis is context-dependent and may require targeted forms/timing.
Actionable Takeaway
Counsel adult patients to perform 1–2 hours per week of resistance training and add regular aerobic activity, emphasizing consistency as the minimum effective dose for longevity and cardiometabolic benefit.
53. The Human Upgrade: Biohacking for Longevity & Performance
Sugar-Free Backlash, Taurine Fail, Copper Brain Therapy, Childhood Biohacking, Strength Training : 1488
Published: 2026-06-19
URL: Listen Here
Summary
This episode challenges simplistic health labels by emphasizing biological mechanisms over marketing: copper modulation to enhance brain protein clearance, the metabolic risks of extreme sugar removal without microbiome support, minimum effective dosing for strength training, SES-driven neurodevelopmental differences, and taurine’s true longer-term roles. The take-home for clinicians is to prioritize mechanism-informed, balanced, and environmental interventions that are consistent and sustainable.
Key Takeaways
A copper-based compound (CuATSM) in an Alzheimer’s mouse model reduced amyloid-β by ~42%, improved spatial memory by ~44%, and increased blood–brain barrier P-glycoprotein by ~24%, highlighting impaired protein clearance—not just overproduction—as a therapeutic target.
Complete removal of sucrose from a low-fat diet in mice (without replacing that substrate) led to insulin resistance, dysbiosis, gut inflammation, and fatty liver despite no weight gain—underscoring that elimination without replacement can harm the microbiome and metabolism.
About 1–2 hours per week of resistance training, especially combined with aerobic exercise, was linked to the clearest reductions in cardiovascular and neurological mortality in a large, long-term observational cohort—consistency beats volume.
Socioeconomic conditions were the strongest predictor of structural brain differences in children (ages 9–10), likely mediated by sleep deprivation, chronic stress, and screen exposure—environmental inputs are biologically inscribed during development.
An acute 1 g dose of taurine 60 minutes before maximal aerobic testing did not improve VO2 max or time-to-exhaustion; taurine’s value is longer-term (e.g., mitochondrial and cardiovascular support, nervous system modulation), with benefits seen at 3–6 g/day over time rather than as an acute performance enhancer.
Clinical Insight
Neurodegeneration risk and progression may hinge as much on restoring clearance (e.g., P-glycoprotein function at the blood–brain barrier) and optimizing systemic inputs (sleep, glycemic control, blood pressure, toxin reduction) as on suppressing pathogenic protein production—pointing to mechanism-based, multimodal care rather than single-target fixes.
Actionable Takeaway
When patients reduce sugars or go low-carb, proactively add microbiome-supportive inputs—aim for 25–35 g/day of mixed dietary fiber, emphasize polyphenol-rich plants, and include fermented foods—to prevent dysbiosis and metabolic deterioration from ‘elimination without replacement.’
54. Huberman Lab
Essentials: Improve Flexibility with Research-Supported Stretching Protocols
Published: 2026-06-18
URL: Listen Here
Summary
This episode explains the neural and tissue mechanisms that govern flexibility and translates current evidence into a simple, low-intensity static stretching protocol that reliably improves ROM. It also addresses timing (post-exercise), warm-up needs, and yoga-related insular adaptations that enhance pain tolerance and relaxation—providing clear guidance for clinicians and athletes.
Key Takeaways
Flexibility is regulated by neural mechanisms (muscle spindles and Golgi tendon organs) and central control (insula and von Economo neurons) in addition to muscle and connective tissue; deliberate downshifting of arousal can help relax into end ranges.
For durable increases in range of motion (ROM), static stretching (including PNF variants) outperforms dynamic/ballistic methods; 30-second holds performed frequently and totaling at least 5 minutes per muscle group per week produce significant gains.
Low-intensity static stretching (~30–40% of the pain threshold, “microstretching”) produces greater ROM improvements than moderate-intensity (~80%) static stretching and likely reduces injury risk.
Warm up first (be ‘core-warm’) and place static stretching after workouts; pre-exercise static holds can acutely impair strength/speed, whereas dynamic/ballistic warm-ups may benefit preparation and movement quality.
Mind–body practices such as yoga are associated with increased insular cortex volume and markedly higher pain tolerance, supporting better interoceptive control and the ability to relax into stretches.
Clinical Insight
Prescribing low-intensity, frequent static stretching with adequate weekly volume (≥5 minutes per muscle group, using 30-second holds) is an evidence-supported, safer way to achieve lasting ROM gains; coach patients to relax into stretches and avoid pre-event static holds for strength/power tasks unless needed to restore safe mechanics.
Actionable Takeaway
For each target muscle group, after training (or after a 5–10 minute light cardio warm-up), perform 3 sets of 30-second low-intensity static holds (about 30–40% of pain threshold) on 5 days per week, accumulating at least 5 minutes/week per muscle group; avoid static stretching immediately before strength/power efforts.
55. The Human Upgrade: Biohacking for Longevity & Performance
Sugar-Free Backlash, Taurine Fail, Copper Brain Therapy, Childhood Biohacking, Strength Training : 1488
Published: 2026-06-19
URL: Listen Here
Summary
This episode challenges common health heuristics by emphasizing mechanisms over labels: supporting brain clearance pathways in neurodegeneration, avoiding unbalanced ‘sugar-free’ extremes that starve the microbiome, aiming for a minimum effective dose of strength training, and recognizing socioeconomic inputs as biological determinants of child brain development. It also reframes taurine as a long-term mitochondrial and cardiovascular support tool rather than an acute performance enhancer—guidance that can refine clinical counseling on lifestyle, supplementation, and prevention.
Key Takeaways
In Alzheimer’s-model mice, the copper complex Cu(ATSM) reduced amyloid-β burden, improved spatial memory, and upregulated P-glycoprotein at the blood–brain barrier, highlighting a clearance-first approach rather than solely attacking amyloid.
Eliminating sucrose from a low-fat diet in mice—without replacing its microbiome substrates—led to insulin resistance, impaired glucose tolerance, gut dysbiosis/inflammation, and fatty liver despite no weight gain, underscoring that the microbiome needs fuel and balance.
About 1–2 hours per week of resistance training, especially when combined with aerobic exercise, was associated with the clearest reductions in cardiovascular and neurological mortality in long-term observational data, reinforcing consistency over volume.
Socioeconomic conditions were the strongest predictor of structural brain differences on MRI among 9–10-year-old children, likely mediated by sleep deprivation, chronic stress, and screen exposure—factors that are modifiable.
A single 1 g dose of taurine one hour pre-exercise did not enhance VO2max or time-to-exhaustion; taurine’s value appears to lie in mitochondrial, cardiovascular, and neuro-modulatory support with chronic dosing (e.g., 3–6 g/day), not acute performance boosts.
Clinical Insight
For patients at risk of cognitive decline, prioritize mechanisms that enhance brain waste clearance (sleep quality, vascular health, metabolic control, toxin reduction, and potentially P-glycoprotein activity) rather than focusing solely on amyloid reduction; copper biology in the brain is nuanced and form- and context-dependent.
Actionable Takeaway
When recommending sugar reduction, proactively replace lost substrates by prescribing 25–35 g/day of dietary fiber plus polyphenol-rich foods (e.g., berries, cocoa, herbs) and fermented foods to support the microbiome and metabolic health.
56. The Peter Attia Drive
#397 ‒ Endometriosis and adenomyosis: diagnosis, fertility, reproductive aging, and emerging treatments | Renato Tomioka, M.D., Ph.D.
Published: 2026-06-22
URL: Listen Here
Summary
This episode details modern diagnosis and management of endometriosis and adenomyosis, emphasizing imaging-based, symptom-driven diagnosis, early hormonal suppression, and selective surgery aligned with fertility goals. It explains how maternal age (via rapidly rising aneuploidy) dominates fertility outcomes, how endometriosis chiefly causes mechanical subfertility, and how adenomyosis undermines implantation, with practical IVF strategies (GnRH suppression, salpingectomy, oocyte/embryo banking). Earlier diagnosis and tailored sequencing of medical, surgical, and fertility interventions can meaningfully improve pain, quality of life, and live-birth rates.
Key Takeaways
Endometriosis (~10% of reproductive-age women; 30–50% among those with infertility) and adenomyosis (likely 20–30%) are estrogen-dependent, progesterone-resistant conditions that often co-occur; diagnostic delays average 5–12 years and increasingly affect adolescents.
Diagnosis has shifted away from diagnostic laparoscopy toward advanced imaging: expert transvaginal ultrasound using a dedicated bowel-prep/sliding-sign protocol and pelvic MRI. A normal routine ultrasound does not rule out disease; ACOG (Mar 2026) supports clinical diagnosis and empiric treatment.
First-line management for pain when pregnancy is not immediately desired is hormonal suppression (continuous progestins, low-dose combined OCPs, or levonorgestrel IUD if no endometrioma), reserving surgery for refractory pain, organ compromise (bowel/ureter), large endometriomas, or to restore tubo-ovarian anatomy; post-op suppression lowers recurrence.
Fertility outcomes are dominated by maternal age via a steep, non-linear rise in embryo aneuploidy after 35; endometriosis mainly impairs fertility mechanically (adhesions/tubal dysfunction), whereas adenomyosis increases miscarriage and reduces IVF success. Treat hydrosalpinx with salpingectomy before IVF; consider oocyte/embryo banking before endometrioma surgery due to AMH loss.
Emerging strategies include GnRH suppression before FET in adenomyosis, a prolactin-receptor monoclonal antibody (HMI-115) in phase 3 as a potential first non-hormonal therapy, broader access to expert imaging, and experimental mitochondrial/gamete approaches that do not yet solve age-related aneuploidy.
Clinical Insight
Do not rely on a ‘normal’ routine pelvic ultrasound or wait for laparoscopy—make a symptom-based clinical diagnosis early, refer for expert endometriosis-protocol ultrasound and/or pelvic MRI, and begin empiric hormonal suppression to prevent central sensitization, reduce disease burden, and preserve fertility.
Actionable Takeaway
For a reproductive-aged patient with cyclic pelvic pain/dyspareunia/dyschezia who is not currently pursuing pregnancy, start continuous progestin therapy (e.g., norethindrone acetate or dienogest) while arranging expert transvaginal ultrasound with a bowel-prep/sliding-sign protocol (and/or pelvic MRI); if hydrosalpinx is identified pre-IVF, plan salpingectomy to improve implantation and live-birth rates.
57. Huberman Lab
Science of Attraction, Compatibility & Romance | Dr. Paul Eastwick
Published: 2026-06-22
URL: Listen Here
Summary
This episode synthesizes data showing that compatibility typically develops over time via shared experiences and reciprocal self‑disclosure, and that widely publicized evolutionary ‘marketplace’ claims are often overstated in real-life interactions. It emphasizes modifiable drivers—secure attachment, robust friend/couple networks, and strong sexual intimacy—while cautioning that apps/social media can distort mate choice and threaten monogamy if boundaries erode. Summary is based on the provided transcript; some in‑episode study specifics may not be fully captured here.
Key Takeaways
Online dating concentrates attention and matches on a small set of highly popular profiles, whereas repeated in‑person interaction fosters idiosyncratic attraction and reduces ‘marketplace’ inequalities.
Revealed (behavioral) preferences differ from stated ones: in face‑to‑face settings men and women show similar weighting of youth and ambition/earning in partners; large sex differences shrink. Men tend to be more eager for commitment and women more likely to initiate breakups.
Attachment orientations are plastic; secure bonds confer health benefits. Many men rely primarily on a partner for support—broadening individual and couple‑friend networks can improve well‑being and relationship stability.
Early attraction is commonly ‘middling’ and grows through reciprocal self‑disclosure and shared narratives (e.g., fast‑friends/“36 questions” approaches); text‑based wit can bias early selection relative to in‑person banter.
Sexual/physical intimacy—and perceiving one’s partner as a ‘good lover’—robustly predicts satisfaction and durability; protective processes (derogation of alternatives) support monogamy, whereas private DM/social media exchanges can erode boundaries if they repeatedly escalate.
Clinical Insight
For clinicians, the strongest modifiable levers of relationship health are sexual/physical intimacy and social connectedness. Screening and supporting these domains—especially by helping men expand support beyond a sole partner and by encouraging patients toward recurring in‑person, small‑group activities—can enhance attachment security, reduce loneliness, and improve relationship stability and mental health.
Actionable Takeaway
At visits for loneliness, stress, or relationship strain, add a 2‑item screen: (1) “Outside your partner, do you have at least one person you could call for support?” (yes/no); (2) “Over the past 2 weeks, how satisfied (0–10) have you been with sexual/physical intimacy in your relationship?” If ‘no’ or ≤6, provide a social prescription for a weekly recurring group activity (e.g., class/team/faith group) and consider referral to couples/sex therapy as indicated.
Actionable Takeaway
Prescribe a weekly “Influence vs Concern” worksheet: have patients list current worries (left column) and only direct-control actions (right), then schedule 1–3 right-column items for the week; augment with a 30-day phone-use cap (≤60 minutes/day) and move all social apps to desktop-only to reduce compulsive use.
Stay connected with Dr Onyx MD PhD for clinical insights and wellness tools that bridge science and everyday care:
Instagram ✦ X (Twitter) ✦ LinkedIn ✦ Website
From Insights to Action
Knowledge without execution changes nothing. The insights above only reach their full potential when integrated into a strategic, personalized plan. That’s where two offerings come in:
Personalized Medical AI Chatbot
Healthcare complexity is overwhelming. Clinical studies, conflicting guidelines, and fragmented records leave most patients paralyzed.
Deploy your Dr Onyx MD PhD Medical AI Chatbot—a personalized architecture that synthesizes your medical history, the latest research, and your unique condition into clear, actionable insights.
It’s not a replacement for your doctors—it’s your secret weapon for making better decisions and becoming the CEO of your own care.
👉 Deploy your Medical AI Chatbot today and take control of your health narrative
Premium Longevity Program
For people who know their most valuable asset is their health.
This year-long partnership delivers clarity, accountability, and physician-led execution. Stop collecting fragmented data and start acting on a ranked, strategic plan tailored to your biology and lifestyle.
👉 Discover the Premium Longevity Program and secure your health as your ultimate investment.